<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4D0382A2-6DA7-4821-B607-0E8282751234"><gtr:id>4D0382A2-6DA7-4821-B607-0E8282751234</gtr:id><gtr:name>University of Colombo</gtr:name><gtr:address><gtr:line1>PO Box 1490</gtr:line1><gtr:line4>Colombo</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Sri Lanka</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/31BAAEA1-1BCB-4D42-B1B3-4FC2539E6F43"><gtr:id>31BAAEA1-1BCB-4D42-B1B3-4FC2539E6F43</gtr:id><gtr:name>Public Health England</gtr:name><gtr:address><gtr:line1>Porton Down</gtr:line1><gtr:line4>Salisbury</gtr:line4><gtr:line5>Wiltshire</gtr:line5><gtr:postCode>SP4 0JG</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/B06DBF11-FCBF-430E-AD9A-D0AE23BFFF60"><gtr:id>B06DBF11-FCBF-430E-AD9A-D0AE23BFFF60</gtr:id><gtr:name>Kwame Nkruma University of Science &amp; Tec</gtr:name><gtr:address><gtr:line1>KNUST</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/E1CC69FF-F01B-4F80-98A2-158B82EFC120"><gtr:id>E1CC69FF-F01B-4F80-98A2-158B82EFC120</gtr:id><gtr:name>Centre Muraz</gtr:name><gtr:address><gtr:line1>Centre Muraz</gtr:line1><gtr:line2>01 PO Box 153</gtr:line2><gtr:line3>Bobo-Dioulasso 01</gtr:line3><gtr:postCode>BP 390</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/B5EF3F61-D9B1-4752-91FA-0E7B5E6FF56C"><gtr:id>B5EF3F61-D9B1-4752-91FA-0E7B5E6FF56C</gtr:id><gtr:name>Pasteur Institute Dakar</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/506B5B88-CD5C-466D-8B68-F3E48DB00C37"><gtr:id>506B5B88-CD5C-466D-8B68-F3E48DB00C37</gtr:id><gtr:name>Addis Ababa University</gtr:name><gtr:address><gtr:line1>Addis Ababa University</gtr:line1><gtr:line2>POBox 1176</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>Ethiopia</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/473F7B5C-70FE-4079-A7A4-9B33054D3495"><gtr:id>473F7B5C-70FE-4079-A7A4-9B33054D3495</gtr:id><gtr:name>University of Rome I (La Sapienza)</gtr:name><gtr:address><gtr:line1>University of Rome</gtr:line1><gtr:line2>Via Pietro Roselli</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>Italy</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2C711771-B8F6-4CDF-9AC3-9FAB317463D9"><gtr:id>2C711771-B8F6-4CDF-9AC3-9FAB317463D9</gtr:id><gtr:name>University of Cape Town</gtr:name><gtr:address><gtr:line1>Private Bag</gtr:line1><gtr:line2>Rondebosch</gtr:line2><gtr:postCode>7700</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>South Africa</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/83131D05-1343-4FD7-B8F6-EE9130AD9AC1"><gtr:id>83131D05-1343-4FD7-B8F6-EE9130AD9AC1</gtr:id><gtr:name>Noguchi Memorial Inst for Medical Res</gtr:name><gtr:address><gtr:line1>College of Health Sciences</gtr:line1><gtr:line2>University of Ghana, Legon</gtr:line2><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/8446A993-B4C4-4CF7-8C31-B7F7566AA246"><gtr:id>8446A993-B4C4-4CF7-8C31-B7F7566AA246</gtr:id><gtr:name>University of Malawi</gtr:name><gtr:address><gtr:line1>P.O. Box 278</gtr:line1><gtr:line4>Zomba</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Malawi</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/131BC483-0A92-40F5-A15E-0A687D7CC55A"><gtr:id>131BC483-0A92-40F5-A15E-0A687D7CC55A</gtr:id><gtr:name>Papua New Guinea Inst of Med Research</gtr:name><gtr:address><gtr:line1>Papua New Guinea Institute of Medical Re</gtr:line1><gtr:line2>PO Box 60</gtr:line2><gtr:postCode>EHP 441</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/8B20E5E6-DA12-4D66-86AD-147848BAC423"><gtr:id>8B20E5E6-DA12-4D66-86AD-147848BAC423</gtr:id><gtr:name>Cote D'Ivoire's National Institute of Public Health</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/57150975-2FFC-442F-A99E-ABD25A46F8D2"><gtr:id>57150975-2FFC-442F-A99E-ABD25A46F8D2</gtr:id><gtr:name>Pasteur Institute, Paris</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/E913F6AA-9FFC-4300-83DB-799EC8F3A4E7"><gtr:id>E913F6AA-9FFC-4300-83DB-799EC8F3A4E7</gtr:id><gtr:name>University of Maryland</gtr:name><gtr:address><gtr:line1>University of Maryland</gtr:line1><gtr:postCode>20742</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/6B538A40-510A-4984-92B4-F4DDAEDFC87E"><gtr:id>6B538A40-510A-4984-92B4-F4DDAEDFC87E</gtr:id><gtr:name>University of Buea</gtr:name><gtr:address><gtr:line1>PO Box 63</gtr:line1><gtr:line2>South West Province</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>Cameroon</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/EEE60C22-8EBE-4EE4-8348-0A16BA1557BE"><gtr:id>EEE60C22-8EBE-4EE4-8348-0A16BA1557BE</gtr:id><gtr:name>Pasteur Institute of Madagascar</gtr:name><gtr:address><gtr:line1>Institute Pasteur de Madagascar</gtr:line1><gtr:line2>BP 1274</gtr:line2><gtr:line3>Ambatofotsikely</gtr:line3><gtr:postCode>101</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C754D612-4D8B-42CB-922C-07E7F5BE4B49"><gtr:id>C754D612-4D8B-42CB-922C-07E7F5BE4B49</gtr:id><gtr:name>Washington University in St. Louis</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/1C4A24DC-2FF4-47B7-B5FA-46BFF24DF5AB"><gtr:id>1C4A24DC-2FF4-47B7-B5FA-46BFF24DF5AB</gtr:id><gtr:name>National Institute for Medical Research</gtr:name><gtr:address><gtr:line1>Ocean Road</gtr:line1><gtr:line2>PO Box 9653</gtr:line2><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/03D3A37D-643A-488B-AED8-221F4741CB5F"><gtr:id>03D3A37D-643A-488B-AED8-221F4741CB5F</gtr:id><gtr:name>Menzies School of Health Research</gtr:name><gtr:address><gtr:line1>P.O. Box 41096</gtr:line1><gtr:line2>Casuarina</gtr:line2><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3C4A98AE-E216-488D-ABD5-B21CD9B10326"><gtr:id>3C4A98AE-E216-488D-ABD5-B21CD9B10326</gtr:id><gtr:name>Institute for Endemic Diseases IEND</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/AE6EAB1A-CC2F-4FDB-A57F-41E76D78ACAB"><gtr:id>AE6EAB1A-CC2F-4FDB-A57F-41E76D78ACAB</gtr:id><gtr:name>Oxford University Hospitals NHS Trust</gtr:name><gtr:address><gtr:line1>Churchill Site</gtr:line1><gtr:line2>Old Road</gtr:line2><gtr:line3>Headington</gtr:line3><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX3 7LJ</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/79DB5830-1026-467B-96BC-633088167D03"><gtr:id>79DB5830-1026-467B-96BC-633088167D03</gtr:id><gtr:name>Universit? des Sciences de la Sant?, Gabon</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/DDD14154-81FB-417E-81AA-AAEA066ECA04"><gtr:id>DDD14154-81FB-417E-81AA-AAEA066ECA04</gtr:id><gtr:name>The Wellcome Trust  Sanger Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:postCode>CB10 1SA</gtr:postCode><gtr:region>East of England</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7"><gtr:id>055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7</gtr:id><gtr:name>London Sch of Hygiene and Trop Medicine</gtr:name><gtr:address><gtr:line1>Keppel Street</gtr:line1><gtr:postCode>WC1E 7HT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/075FAA3F-6CD7-4D3E-A0B2-5FD2B06A7699"><gtr:id>075FAA3F-6CD7-4D3E-A0B2-5FD2B06A7699</gtr:id><gtr:name>Congo National Institute of Biomedical Research (Institut National de Recherche Biom?dicale)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/734F19C1-61E5-45B1-A183-63FDD145328F"><gtr:id>734F19C1-61E5-45B1-A183-63FDD145328F</gtr:id><gtr:name>World Health Organization (WHO)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/80392F0C-23A4-449D-BC8D-4D77C0F53303"><gtr:id>80392F0C-23A4-449D-BC8D-4D77C0F53303</gtr:id><gtr:name>Mahidol University</gtr:name><gtr:address><gtr:line1>Mahidol University</gtr:line1><gtr:line2>Office of the President  Mahidol Univers</gtr:line2><gtr:line3>25/25 Moo 3, Phuttamonthon 4 Road</gtr:line3><gtr:postCode>73170</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/B16D710A-5C40-44CA-A796-B37EC8935E99"><gtr:id>B16D710A-5C40-44CA-A796-B37EC8935E99</gtr:id><gtr:name>University of Michigan</gtr:name><gtr:address><gtr:line1>3003 S. State Street</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/845F7CA5-F786-40DF-B429-C727CA83C9CF"><gtr:id>845F7CA5-F786-40DF-B429-C727CA83C9CF</gtr:id><gtr:name>University of Bamako</gtr:name><gtr:address><gtr:line1>University of Bamako</gtr:line1><gtr:line3>Darsalam</gtr:line3><gtr:postCode>BP276</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/11E604AE-3915-4673-AEA6-852F7D6BFFD8"><gtr:id>11E604AE-3915-4673-AEA6-852F7D6BFFD8</gtr:id><gtr:name>Wellcome Trust</gtr:name><gtr:address><gtr:line1>183 EUSTON ROAD</gtr:line1><gtr:city>LONDON</gtr:city><gtr:postCode>NW1  2BE</gtr:postCode><gtr:region>London</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4D7B1201-735F-4387-BEF2-62D3BF8C522E"><gtr:id>4D7B1201-735F-4387-BEF2-62D3BF8C522E</gtr:id><gtr:name>Navrongo Health Research Centre (NHRC)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/6DCA7B7A-0111-4A7C-95CC-DEAD58B89132"><gtr:id>6DCA7B7A-0111-4A7C-95CC-DEAD58B89132</gtr:id><gtr:name>University of Stockholm</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3ED60B49-9C2B-4D71-B644-96CCC7F10194"><gtr:id>3ED60B49-9C2B-4D71-B644-96CCC7F10194</gtr:id><gtr:name>Liverpool School of Tropical Medicine</gtr:name><gtr:address><gtr:line1>School Of Tropical Medicine</gtr:line1><gtr:line2>Pembroke Place</gtr:line2><gtr:postCode>L3 5QA</gtr:postCode><gtr:region>North West</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:department>Wellcome Trust Centre for Human Genetics</gtr:department><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4D0382A2-6DA7-4821-B607-0E8282751234"><gtr:id>4D0382A2-6DA7-4821-B607-0E8282751234</gtr:id><gtr:name>University of Colombo</gtr:name><gtr:address><gtr:line1>PO Box 1490</gtr:line1><gtr:line4>Colombo</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Sri Lanka</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/31BAAEA1-1BCB-4D42-B1B3-4FC2539E6F43"><gtr:id>31BAAEA1-1BCB-4D42-B1B3-4FC2539E6F43</gtr:id><gtr:name>Public Health England</gtr:name><gtr:address><gtr:line1>Porton Down</gtr:line1><gtr:line4>Salisbury</gtr:line4><gtr:line5>Wiltshire</gtr:line5><gtr:postCode>SP4 0JG</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/B06DBF11-FCBF-430E-AD9A-D0AE23BFFF60"><gtr:id>B06DBF11-FCBF-430E-AD9A-D0AE23BFFF60</gtr:id><gtr:name>Kwame Nkruma University of Science &amp; Tec</gtr:name><gtr:address><gtr:line1>KNUST</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E1CC69FF-F01B-4F80-98A2-158B82EFC120"><gtr:id>E1CC69FF-F01B-4F80-98A2-158B82EFC120</gtr:id><gtr:name>Centre Muraz</gtr:name><gtr:address><gtr:line1>Centre Muraz</gtr:line1><gtr:line2>01 PO Box 153</gtr:line2><gtr:line3>Bobo-Dioulasso 01</gtr:line3><gtr:postCode>BP 390</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/B5EF3F61-D9B1-4752-91FA-0E7B5E6FF56C"><gtr:id>B5EF3F61-D9B1-4752-91FA-0E7B5E6FF56C</gtr:id><gtr:name>Pasteur Institute Dakar</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/506B5B88-CD5C-466D-8B68-F3E48DB00C37"><gtr:id>506B5B88-CD5C-466D-8B68-F3E48DB00C37</gtr:id><gtr:name>Addis Ababa University</gtr:name><gtr:address><gtr:line1>Addis Ababa University</gtr:line1><gtr:line2>POBox 1176</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>Ethiopia</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/473F7B5C-70FE-4079-A7A4-9B33054D3495"><gtr:id>473F7B5C-70FE-4079-A7A4-9B33054D3495</gtr:id><gtr:name>University of Rome I (La Sapienza)</gtr:name><gtr:address><gtr:line1>University of Rome</gtr:line1><gtr:line2>Via Pietro Roselli</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>Italy</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2C711771-B8F6-4CDF-9AC3-9FAB317463D9"><gtr:id>2C711771-B8F6-4CDF-9AC3-9FAB317463D9</gtr:id><gtr:name>University of Cape Town</gtr:name><gtr:address><gtr:line1>Private Bag</gtr:line1><gtr:line2>Rondebosch</gtr:line2><gtr:postCode>7700</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>South Africa</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/83131D05-1343-4FD7-B8F6-EE9130AD9AC1"><gtr:id>83131D05-1343-4FD7-B8F6-EE9130AD9AC1</gtr:id><gtr:name>Noguchi Memorial Inst for Medical Res</gtr:name><gtr:address><gtr:line1>College of Health Sciences</gtr:line1><gtr:line2>University of Ghana, Legon</gtr:line2><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/8446A993-B4C4-4CF7-8C31-B7F7566AA246"><gtr:id>8446A993-B4C4-4CF7-8C31-B7F7566AA246</gtr:id><gtr:name>University of Malawi</gtr:name><gtr:address><gtr:line1>P.O. Box 278</gtr:line1><gtr:line4>Zomba</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Malawi</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/131BC483-0A92-40F5-A15E-0A687D7CC55A"><gtr:id>131BC483-0A92-40F5-A15E-0A687D7CC55A</gtr:id><gtr:name>Papua New Guinea Inst of Med Research</gtr:name><gtr:address><gtr:line1>Papua New Guinea Institute of Medical Re</gtr:line1><gtr:line2>PO Box 60</gtr:line2><gtr:postCode>EHP 441</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/8B20E5E6-DA12-4D66-86AD-147848BAC423"><gtr:id>8B20E5E6-DA12-4D66-86AD-147848BAC423</gtr:id><gtr:name>Cote D'Ivoire's National Institute of Public Health</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/57150975-2FFC-442F-A99E-ABD25A46F8D2"><gtr:id>57150975-2FFC-442F-A99E-ABD25A46F8D2</gtr:id><gtr:name>Pasteur Institute, Paris</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E913F6AA-9FFC-4300-83DB-799EC8F3A4E7"><gtr:id>E913F6AA-9FFC-4300-83DB-799EC8F3A4E7</gtr:id><gtr:name>University of Maryland</gtr:name><gtr:address><gtr:line1>University of Maryland</gtr:line1><gtr:postCode>20742</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/6B538A40-510A-4984-92B4-F4DDAEDFC87E"><gtr:id>6B538A40-510A-4984-92B4-F4DDAEDFC87E</gtr:id><gtr:name>University of Buea</gtr:name><gtr:address><gtr:line1>PO Box 63</gtr:line1><gtr:line2>South West Province</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>Cameroon</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/EEE60C22-8EBE-4EE4-8348-0A16BA1557BE"><gtr:id>EEE60C22-8EBE-4EE4-8348-0A16BA1557BE</gtr:id><gtr:name>Pasteur Institute of Madagascar</gtr:name><gtr:address><gtr:line1>Institute Pasteur de Madagascar</gtr:line1><gtr:line2>BP 1274</gtr:line2><gtr:line3>Ambatofotsikely</gtr:line3><gtr:postCode>101</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C754D612-4D8B-42CB-922C-07E7F5BE4B49"><gtr:id>C754D612-4D8B-42CB-922C-07E7F5BE4B49</gtr:id><gtr:name>Washington University in St. Louis</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/1C4A24DC-2FF4-47B7-B5FA-46BFF24DF5AB"><gtr:id>1C4A24DC-2FF4-47B7-B5FA-46BFF24DF5AB</gtr:id><gtr:name>National Institute for Medical Research</gtr:name><gtr:address><gtr:line1>Ocean Road</gtr:line1><gtr:line2>PO Box 9653</gtr:line2><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/03D3A37D-643A-488B-AED8-221F4741CB5F"><gtr:id>03D3A37D-643A-488B-AED8-221F4741CB5F</gtr:id><gtr:name>Menzies School of Health Research</gtr:name><gtr:address><gtr:line1>P.O. Box 41096</gtr:line1><gtr:line2>Casuarina</gtr:line2><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3C4A98AE-E216-488D-ABD5-B21CD9B10326"><gtr:id>3C4A98AE-E216-488D-ABD5-B21CD9B10326</gtr:id><gtr:name>Institute for Endemic Diseases IEND</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AE6EAB1A-CC2F-4FDB-A57F-41E76D78ACAB"><gtr:id>AE6EAB1A-CC2F-4FDB-A57F-41E76D78ACAB</gtr:id><gtr:name>Oxford University Hospitals NHS Trust</gtr:name><gtr:address><gtr:line1>Churchill Site</gtr:line1><gtr:line2>Old Road</gtr:line2><gtr:line3>Headington</gtr:line3><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX3 7LJ</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/79DB5830-1026-467B-96BC-633088167D03"><gtr:id>79DB5830-1026-467B-96BC-633088167D03</gtr:id><gtr:name>Universit? des Sciences de la Sant?, Gabon</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DDD14154-81FB-417E-81AA-AAEA066ECA04"><gtr:id>DDD14154-81FB-417E-81AA-AAEA066ECA04</gtr:id><gtr:name>The Wellcome Trust  Sanger Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:postCode>CB10 1SA</gtr:postCode><gtr:region>East of England</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7"><gtr:id>055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7</gtr:id><gtr:name>London Sch of Hygiene and Trop Medicine</gtr:name><gtr:address><gtr:line1>Keppel Street</gtr:line1><gtr:postCode>WC1E 7HT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/075FAA3F-6CD7-4D3E-A0B2-5FD2B06A7699"><gtr:id>075FAA3F-6CD7-4D3E-A0B2-5FD2B06A7699</gtr:id><gtr:name>Congo National Institute of Biomedical Research (Institut National de Recherche Biom?dicale)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/734F19C1-61E5-45B1-A183-63FDD145328F"><gtr:id>734F19C1-61E5-45B1-A183-63FDD145328F</gtr:id><gtr:name>World Health Organization (WHO)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/80392F0C-23A4-449D-BC8D-4D77C0F53303"><gtr:id>80392F0C-23A4-449D-BC8D-4D77C0F53303</gtr:id><gtr:name>Mahidol University</gtr:name><gtr:address><gtr:line1>Mahidol University</gtr:line1><gtr:line2>Office of the President  Mahidol Univers</gtr:line2><gtr:line3>25/25 Moo 3, Phuttamonthon 4 Road</gtr:line3><gtr:postCode>73170</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/B16D710A-5C40-44CA-A796-B37EC8935E99"><gtr:id>B16D710A-5C40-44CA-A796-B37EC8935E99</gtr:id><gtr:name>University of Michigan</gtr:name><gtr:address><gtr:line1>3003 S. State Street</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/845F7CA5-F786-40DF-B429-C727CA83C9CF"><gtr:id>845F7CA5-F786-40DF-B429-C727CA83C9CF</gtr:id><gtr:name>University of Bamako</gtr:name><gtr:address><gtr:line1>University of Bamako</gtr:line1><gtr:line3>Darsalam</gtr:line3><gtr:postCode>BP276</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/11E604AE-3915-4673-AEA6-852F7D6BFFD8"><gtr:id>11E604AE-3915-4673-AEA6-852F7D6BFFD8</gtr:id><gtr:name>Wellcome Trust</gtr:name><gtr:address><gtr:line1>183 EUSTON ROAD</gtr:line1><gtr:city>LONDON</gtr:city><gtr:postCode>NW1  2BE</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4D7B1201-735F-4387-BEF2-62D3BF8C522E"><gtr:id>4D7B1201-735F-4387-BEF2-62D3BF8C522E</gtr:id><gtr:name>Navrongo Health Research Centre (NHRC)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/6DCA7B7A-0111-4A7C-95CC-DEAD58B89132"><gtr:id>6DCA7B7A-0111-4A7C-95CC-DEAD58B89132</gtr:id><gtr:name>University of Stockholm</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3ED60B49-9C2B-4D71-B644-96CCC7F10194"><gtr:id>3ED60B49-9C2B-4D71-B644-96CCC7F10194</gtr:id><gtr:name>Liverpool School of Tropical Medicine</gtr:name><gtr:address><gtr:line1>School Of Tropical Medicine</gtr:line1><gtr:line2>Pembroke Place</gtr:line2><gtr:postCode>L3 5QA</gtr:postCode><gtr:region>North West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/CB0D71D3-7812-42A2-A84E-E97C6FE2D582"><gtr:id>CB0D71D3-7812-42A2-A84E-E97C6FE2D582</gtr:id><gtr:firstName>Dominic</gtr:firstName><gtr:otherNames>Peter</gtr:otherNames><gtr:surname>Kwiatkowski</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0600718"><gtr:id>ED26A798-EADF-48CC-8BBA-10CDB3AB911E</gtr:id><gtr:title>MRC Centre for Genomics and Global Health</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0600718</gtr:grantReference><gtr:abstractText>Among the biggest challenges in medical research are (1) to develop effective vaccines against malaria, HIV/AIDS and tuberculosis, which together account for a massive global burden of disease, particularly in the developing world; (2) to combat drug resistance in malaria, HIV/AIDS, tuberculosis, enteric bacteria, invasive bacteria and other pathogens; (3) to combat the emergence of virulent pathogens such as pandemic influenza. Underlying these practical problems in global health is the biological phenomenon of genome diversity. Pathogen genomes are continually evolving in response to human immune pressure and prevailing drug usage; while at the same time infectious diseases are a major force for evolutionary selection of the human genome. Although genome diversity is a large part of the problem in infectious disease, it also offers a scientific route to understanding natural mechanisms of disease and immunity. Epidemiological analysis of the clinical consequences of pathogen genome variation may be highly informative about pathogen mechanisms of virulence, drug resistance and immune evasion. Equally, epidemiological analysis of the clinical consequences of human genome variation may be highly informative about host mechanisms of defence and protective immunity. The aim of this Translational Centre proposal is to develop the scientific environment and technical infrastructure needed to apply genomic epidemiology to practical lessons about disease prevention ? particularly about drug resistance and vaccine development.</gtr:abstractText><gtr:technicalSummary>The mission of this Translational Centre is to translate state-of-the-art research on human and pathogen genome variation into large-scale clinical and epidemiological investigations of practical relevance for global health.

We will develop informatic systems and data-sharing standards to integrate clinical and epidemiological studies at the MRC Laboratories in The Gambia, the KEMRI/Wellcome Unit in Kenya and the Wellcome Units in Vietnam and Thailand, with high-throughput genome technologies, bioinformatics and statistical genetics at Oxford University and the Sanger Institute.

We will use these systems to accelerate vaccine development and to tackle drug resistance in malaria by investigating the clinical and biological consequences of variations in the human genome and in the Plasmodium falciparum genome in malaria-exposed populations.

The systems and tools that we develop will also support genome research on other diseases that are being investigated in the Gambian, Kenyan, Vietnamese and Thai units, including influenza, enteric bacteria, tuberculosis, HIV/AIDS, dengue, chlamydia, bacterial meningitis and pneumococcal disease.</gtr:technicalSummary><gtr:fund><gtr:end>2014-10-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2008-04-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>3115095</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Colombo</gtr:collaboratingOrganisation><gtr:country>Sri Lanka, Democratic Socialist Republic of</gtr:country><gtr:department>Department of Parasitology</gtr:department><gtr:description>Malaria Genomic Epidemiology Network (MalariaGEN)</gtr:description><gtr:id>8EFBDD0A-64E1-400B-905F-DD7858388769</gtr:id><gtr:impact>See www.malariagen.net. Outputs are given in more detail in G0600718B. They include the development of the major global repository of samples and data for genomic epidemiology studies of malaria; and large-scale GWAS and genome sequencing data generation for host, parasite and vector.

Examples relevant to this grant:
1. The world's largest repository of DNA samples and clinical data for genetic studies of host-parasite interactions in malaria
2. Publication of the first genome-wide association study of human disease susceptibility in Africa
3. A large multicentre case-control study of severe malaria, representing the largest ongoing genome-wide association study of an infectious disease. In December 2011 we completed genotyping of &amp;gt;1 million SNPs on &amp;gt;20,000 individuals from 10 different populations.</gtr:impact><gtr:outcomeId>EJCE3jdbkTJ-21</gtr:outcomeId><gtr:partnerContribution>MalariaGEN - the Malaria Genomic Epidemiology Network - is a community of more than 100 researchers in 30 countries, working together on projects that require sharing and integration of large amounts of data.

MalariaGEN brings together the work of many different partner studies, each of which is led by an independent investigator and has its own scientific objectives. MalariaGEN adds value to partner studies by providing access to genotyping and sequencing technologies, and by providing a framework for sharing and integrating data in consortial and community projects. 

MalariaGEN provides training and support in genetic data analysis for researchers at partner institutions in malaria-endemic countries. We do this through a data bursary scheme and through an active programme of scientific meetings and training workshops. These activities are supported by the MalariaGEN Resource Centre which has a team of experts in statistics, population genetics and bioinformatics at the Sanger Institute, Oxford University, the London School of Hygiene and Tropical Medicine, and Mahidol University in Bangkok.

There are many practical and ethical challenges involved in sharing data across a global network comprising investigators and institutions with great disparities in funding and infrastructure. The MalariaGEN community has been working to develop transparent procedures for ethics and governance. We have a governance committee and an independent data access committee, and network policies have been defined for data sharing and data access.</gtr:partnerContribution><gtr:piContribution>I direct the MalariaGEN Resource Centre (http://www.malariagen.net/). CGGH supports Resource Centre activities, particularly statistics, software engineering, and ethics.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Institute for Endemic Diseases IEND</gtr:collaboratingOrganisation><gtr:country>Sudan, Republic of</gtr:country><gtr:description>Malaria Genomic Epidemiology Network (MalariaGEN)</gtr:description><gtr:id>E5651D29-65AE-4E62-B649-B4196BC46437</gtr:id><gtr:impact>See www.malariagen.net. Outputs are given in more detail in G0600718B. They include the development of the major global repository of samples and data for genomic epidemiology studies of malaria; and large-scale GWAS and genome sequencing data generation for host, parasite and vector.

Examples relevant to this grant:
1. The world's largest repository of DNA samples and clinical data for genetic studies of host-parasite interactions in malaria
2. Publication of the first genome-wide association study of human disease susceptibility in Africa
3. A large multicentre case-control study of severe malaria, representing the largest ongoing genome-wide association study of an infectious disease. In December 2011 we completed genotyping of &amp;gt;1 million SNPs on &amp;gt;20,000 individuals from 10 different populations.</gtr:impact><gtr:outcomeId>EJCE3jdbkTJ-20</gtr:outcomeId><gtr:partnerContribution>MalariaGEN - the Malaria Genomic Epidemiology Network - is a community of more than 100 researchers in 30 countries, working together on projects that require sharing and integration of large amounts of data.

MalariaGEN brings together the work of many different partner studies, each of which is led by an independent investigator and has its own scientific objectives. MalariaGEN adds value to partner studies by providing access to genotyping and sequencing technologies, and by providing a framework for sharing and integrating data in consortial and community projects. 

MalariaGEN provides training and support in genetic data analysis for researchers at partner institutions in malaria-endemic countries. We do this through a data bursary scheme and through an active programme of scientific meetings and training workshops. These activities are supported by the MalariaGEN Resource Centre which has a team of experts in statistics, population genetics and bioinformatics at the Sanger Institute, Oxford University, the London School of Hygiene and Tropical Medicine, and Mahidol University in Bangkok.

There are many practical and ethical challenges involved in sharing data across a global network comprising investigators and institutions with great disparities in funding and infrastructure. The MalariaGEN community has been working to develop transparent procedures for ethics and governance. We have a governance committee and an independent data access committee, and network policies have been defined for data sharing and data access.</gtr:partnerContribution><gtr:piContribution>I direct the MalariaGEN Resource Centre (http://www.malariagen.net/). CGGH supports Resource Centre activities, particularly statistics, software engineering, and ethics.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institute for Medical Research, Tanzania</gtr:collaboratingOrganisation><gtr:country>Tanzania, United Republic of</gtr:country><gtr:department>NIMR Mbeya Research Centre (Formerly known as; Mbeya Medical Research Programme, MMPR)</gtr:department><gtr:description>Plasmodium Diversity Network Africa</gtr:description><gtr:id>2D4E740D-82EE-41B1-B0FC-6E42B002EE3D</gtr:id><gtr:impact>Since established there are two PDNA led publications and &amp;pound;5m grant funding through the Wellcome Trust Developing Excellence in Leadership, Training and Science Initiative.</gtr:impact><gtr:outcomeId>hobsd8mnVn4-3</gtr:outcomeId><gtr:partnerContribution>The Plasmodium Diversity Network Africa (PDNA) is a partnership of African scientists working together to determine the diversity of the malaria parasite in sub-Saharan Africa and by using this data, inform malaria control policy. PDNA members are leading research programmes in their own contexts and are part of the training and capacity development of early career African scientists.</gtr:partnerContribution><gtr:piContribution>CGGH has provided small starter grants to PDNA, in part by MRC Centenary Award, as part of our mission to support the training and capacity development of early career African scientists. CGGH continues to support PDNA is various ways including supporting training and providing mentor ship.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Centre Muraz</gtr:collaboratingOrganisation><gtr:country>Burkina Faso</gtr:country><gtr:description>Malaria Genomic Epidemiology Network (MalariaGEN)</gtr:description><gtr:id>A77802B2-969B-483F-98F8-D173ED29D100</gtr:id><gtr:impact>See www.malariagen.net. Outputs are given in more detail in G0600718B. They include the development of the major global repository of samples and data for genomic epidemiology studies of malaria; and large-scale GWAS and genome sequencing data generation for host, parasite and vector.

Examples relevant to this grant:
1. The world's largest repository of DNA samples and clinical data for genetic studies of host-parasite interactions in malaria
2. Publication of the first genome-wide association study of human disease susceptibility in Africa
3. A large multicentre case-control study of severe malaria, representing the largest ongoing genome-wide association study of an infectious disease. In December 2011 we completed genotyping of &amp;gt;1 million SNPs on &amp;gt;20,000 individuals from 10 different populations.</gtr:impact><gtr:outcomeId>EJCE3jdbkTJ-12</gtr:outcomeId><gtr:partnerContribution>MalariaGEN - the Malaria Genomic Epidemiology Network - is a community of more than 100 researchers in 30 countries, working together on projects that require sharing and integration of large amounts of data.

MalariaGEN brings together the work of many different partner studies, each of which is led by an independent investigator and has its own scientific objectives. MalariaGEN adds value to partner studies by providing access to genotyping and sequencing technologies, and by providing a framework for sharing and integrating data in consortial and community projects. 

MalariaGEN provides training and support in genetic data analysis for researchers at partner institutions in malaria-endemic countries. We do this through a data bursary scheme and through an active programme of scientific meetings and training workshops. These activities are supported by the MalariaGEN Resource Centre which has a team of experts in statistics, population genetics and bioinformatics at the Sanger Institute, Oxford University, the London School of Hygiene and Tropical Medicine, and Mahidol University in Bangkok.

There are many practical and ethical challenges involved in sharing data across a global network comprising investigators and institutions with great disparities in funding and infrastructure. The MalariaGEN community has been working to develop transparent procedures for ethics and governance. We have a governance committee and an independent data access committee, and network policies have been defined for data sharing and data access.</gtr:partnerContribution><gtr:piContribution>I direct the MalariaGEN Resource Centre (http://www.malariagen.net/). CGGH supports Resource Centre activities, particularly statistics, software engineering, and ethics.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Maryland</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Centre for Vaccine Development (CVD)</gtr:department><gtr:description>Malaria Genomic Epidemiology Network (MalariaGEN)</gtr:description><gtr:id>7C216FF6-E27F-4EF0-803B-C20E9BE2ED3C</gtr:id><gtr:impact>See www.malariagen.net. Outputs are given in more detail in G0600718B. They include the development of the major global repository of samples and data for genomic epidemiology studies of malaria; and large-scale GWAS and genome sequencing data generation for host, parasite and vector.

Examples relevant to this grant:
1. The world's largest repository of DNA samples and clinical data for genetic studies of host-parasite interactions in malaria
2. Publication of the first genome-wide association study of human disease susceptibility in Africa
3. A large multicentre case-control study of severe malaria, representing the largest ongoing genome-wide association study of an infectious disease. In December 2011 we completed genotyping of &amp;gt;1 million SNPs on &amp;gt;20,000 individuals from 10 different populations.</gtr:impact><gtr:outcomeId>EJCE3jdbkTJ-22</gtr:outcomeId><gtr:partnerContribution>MalariaGEN - the Malaria Genomic Epidemiology Network - is a community of more than 100 researchers in 30 countries, working together on projects that require sharing and integration of large amounts of data.

MalariaGEN brings together the work of many different partner studies, each of which is led by an independent investigator and has its own scientific objectives. MalariaGEN adds value to partner studies by providing access to genotyping and sequencing technologies, and by providing a framework for sharing and integrating data in consortial and community projects. 

MalariaGEN provides training and support in genetic data analysis for researchers at partner institutions in malaria-endemic countries. We do this through a data bursary scheme and through an active programme of scientific meetings and training workshops. These activities are supported by the MalariaGEN Resource Centre which has a team of experts in statistics, population genetics and bioinformatics at the Sanger Institute, Oxford University, the London School of Hygiene and Tropical Medicine, and Mahidol University in Bangkok.

There are many practical and ethical challenges involved in sharing data across a global network comprising investigators and institutions with great disparities in funding and infrastructure. The MalariaGEN community has been working to develop transparent procedures for ethics and governance. We have a governance committee and an independent data access committee, and network policies have been defined for data sharing and data access.</gtr:partnerContribution><gtr:piContribution>I direct the MalariaGEN Resource Centre (http://www.malariagen.net/). CGGH supports Resource Centre activities, particularly statistics, software engineering, and ethics.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Pasteur Institute of Madagascar</gtr:collaboratingOrganisation><gtr:country>Madagascar, Republic of</gtr:country><gtr:description>Plasmodium Diversity Network Africa</gtr:description><gtr:id>97D74E0A-3B4A-4347-B61B-2463CF4A622F</gtr:id><gtr:impact>Since established there are two PDNA led publications and &amp;pound;5m grant funding through the Wellcome Trust Developing Excellence in Leadership, Training and Science Initiative.</gtr:impact><gtr:outcomeId>hobsd8mnVn4-10</gtr:outcomeId><gtr:partnerContribution>The Plasmodium Diversity Network Africa (PDNA) is a partnership of African scientists working together to determine the diversity of the malaria parasite in sub-Saharan Africa and by using this data, inform malaria control policy. PDNA members are leading research programmes in their own contexts and are part of the training and capacity development of early career African scientists.</gtr:partnerContribution><gtr:piContribution>CGGH has provided small starter grants to PDNA, in part by MRC Centenary Award, as part of our mission to support the training and capacity development of early career African scientists. CGGH continues to support PDNA is various ways including supporting training and providing mentor ship.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institute for Medical Research, Tanzania</gtr:collaboratingOrganisation><gtr:country>Tanzania, United Republic of</gtr:country><gtr:description>Malaria Genomic Epidemiology Network (MalariaGEN)</gtr:description><gtr:id>492A9C0A-52D6-4595-9527-9ACE8F62E279</gtr:id><gtr:impact>See www.malariagen.net. Outputs are given in more detail in G0600718B. They include the development of the major global repository of samples and data for genomic epidemiology studies of malaria; and large-scale GWAS and genome sequencing data generation for host, parasite and vector.

Examples relevant to this grant:
1. The world's largest repository of DNA samples and clinical data for genetic studies of host-parasite interactions in malaria
2. Publication of the first genome-wide association study of human disease susceptibility in Africa
3. A large multicentre case-control study of severe malaria, representing the largest ongoing genome-wide association study of an infectious disease. In December 2011 we completed genotyping of &amp;gt;1 million SNPs on &amp;gt;20,000 individuals from 10 different populations.</gtr:impact><gtr:outcomeId>EJCE3jdbkTJ-15</gtr:outcomeId><gtr:partnerContribution>MalariaGEN - the Malaria Genomic Epidemiology Network - is a community of more than 100 researchers in 30 countries, working together on projects that require sharing and integration of large amounts of data.

MalariaGEN brings together the work of many different partner studies, each of which is led by an independent investigator and has its own scientific objectives. MalariaGEN adds value to partner studies by providing access to genotyping and sequencing technologies, and by providing a framework for sharing and integrating data in consortial and community projects. 

MalariaGEN provides training and support in genetic data analysis for researchers at partner institutions in malaria-endemic countries. We do this through a data bursary scheme and through an active programme of scientific meetings and training workshops. These activities are supported by the MalariaGEN Resource Centre which has a team of experts in statistics, population genetics and bioinformatics at the Sanger Institute, Oxford University, the London School of Hygiene and Tropical Medicine, and Mahidol University in Bangkok.

There are many practical and ethical challenges involved in sharing data across a global network comprising investigators and institutions with great disparities in funding and infrastructure. The MalariaGEN community has been working to develop transparent procedures for ethics and governance. We have a governance committee and an independent data access committee, and network policies have been defined for data sharing and data access.</gtr:partnerContribution><gtr:piContribution>I direct the MalariaGEN Resource Centre (http://www.malariagen.net/). CGGH supports Resource Centre activities, particularly statistics, software engineering, and ethics.</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Kwame Nkrumah University of Science and Technology (KNUST)</gtr:collaboratingOrganisation><gtr:country>Ghana, Republic of</gtr:country><gtr:description>Malaria Genomic Epidemiology Network (MalariaGEN)</gtr:description><gtr:id>1A24A52A-F19E-43BC-BF3B-DFD9A63453C5</gtr:id><gtr:impact>See www.malariagen.net. Outputs are given in more detail in G0600718B. They include the development of the major global repository of samples and data for genomic epidemiology studies of malaria; and large-scale GWAS and genome sequencing data generation for host, parasite and vector.

Examples relevant to this grant:
1. The world's largest repository of DNA samples and clinical data for genetic studies of host-parasite interactions in malaria
2. Publication of the first genome-wide association study of human disease susceptibility in Africa
3. A large multicentre case-control study of severe malaria, representing the largest ongoing genome-wide association study of an infectious disease. In December 2011 we completed genotyping of &amp;gt;1 million SNPs on &amp;gt;20,000 individuals from 10 different populations.</gtr:impact><gtr:outcomeId>EJCE3jdbkTJ-10</gtr:outcomeId><gtr:partnerContribution>MalariaGEN - the Malaria Genomic Epidemiology Network - is a community of more than 100 researchers in 30 countries, working together on projects that require sharing and integration of large amounts of data.

MalariaGEN brings together the work of many different partner studies, each of which is led by an independent investigator and has its own scientific objectives. MalariaGEN adds value to partner studies by providing access to genotyping and sequencing technologies, and by providing a framework for sharing and integrating data in consortial and community projects. 

MalariaGEN provides training and support in genetic data analysis for researchers at partner institutions in malaria-endemic countries. We do this through a data bursary scheme and through an active programme of scientific meetings and training workshops. These activities are supported by the MalariaGEN Resource Centre which has a team of experts in statistics, population genetics and bioinformatics at the Sanger Institute, Oxford University, the London School of Hygiene and Tropical Medicine, and Mahidol University in Bangkok.

There are many practical and ethical challenges involved in sharing data across a global network comprising investigators and institutions with great disparities in funding and infrastructure. The MalariaGEN community has been working to develop transparent procedures for ethics and governance. We have a governance committee and an independent data access committee, and network policies have been defined for data sharing and data access.</gtr:partnerContribution><gtr:piContribution>I direct the MalariaGEN Resource Centre (http://www.malariagen.net/). CGGH supports Resource Centre activities, particularly statistics, software engineering, and ethics.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Navrongo Health Research Centre (NHRC)</gtr:collaboratingOrganisation><gtr:country>Ghana, Republic of</gtr:country><gtr:description>Plasmodium Diversity Network Africa</gtr:description><gtr:id>B9F980F4-F3BC-4C8A-A40A-BFEBFD6FB842</gtr:id><gtr:impact>Since established there are two PDNA led publications and &amp;pound;5m grant funding through the Wellcome Trust Developing Excellence in Leadership, Training and Science Initiative.</gtr:impact><gtr:outcomeId>hobsd8mnVn4-4</gtr:outcomeId><gtr:partnerContribution>The Plasmodium Diversity Network Africa (PDNA) is a partnership of African scientists working together to determine the diversity of the malaria parasite in sub-Saharan Africa and by using this data, inform malaria control policy. PDNA members are leading research programmes in their own contexts and are part of the training and capacity development of early career African scientists.</gtr:partnerContribution><gtr:piContribution>CGGH has provided small starter grants to PDNA, in part by MRC Centenary Award, as part of our mission to support the training and capacity development of early career African scientists. CGGH continues to support PDNA is various ways including supporting training and providing mentor ship.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Buea</gtr:collaboratingOrganisation><gtr:country>Cameroon, Republic of</gtr:country><gtr:department>Department of Biochemistry and Microbiology</gtr:department><gtr:description>Plasmodium Diversity Network Africa</gtr:description><gtr:id>732D90F8-509F-49E2-BA62-C0E20A68D763</gtr:id><gtr:impact>Since established there are two PDNA led publications and &amp;pound;5m grant funding through the Wellcome Trust Developing Excellence in Leadership, Training and Science Initiative.</gtr:impact><gtr:outcomeId>hobsd8mnVn4-2</gtr:outcomeId><gtr:partnerContribution>The Plasmodium Diversity Network Africa (PDNA) is a partnership of African scientists working together to determine the diversity of the malaria parasite in sub-Saharan Africa and by using this data, inform malaria control policy. PDNA members are leading research programmes in their own contexts and are part of the training and capacity development of early career African scientists.</gtr:partnerContribution><gtr:piContribution>CGGH has provided small starter grants to PDNA, in part by MRC Centenary Award, as part of our mission to support the training and capacity development of early career African scientists. CGGH continues to support PDNA is various ways including supporting training and providing mentor ship.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Malawi</gtr:collaboratingOrganisation><gtr:country>Malawi, Republic of</gtr:country><gtr:description>Malaria Genomic Epidemiology Network (MalariaGEN)</gtr:description><gtr:id>0F73B771-9B86-4EA1-95B0-149FF33116E0</gtr:id><gtr:impact>See www.malariagen.net. Outputs are given in more detail in G0600718B. They include the development of the major global repository of samples and data for genomic epidemiology studies of malaria; and large-scale GWAS and genome sequencing data generation for host, parasite and vector.

Examples relevant to this grant:
1. The world's largest repository of DNA samples and clinical data for genetic studies of host-parasite interactions in malaria
2. Publication of the first genome-wide association study of human disease susceptibility in Africa
3. A large multicentre case-control study of severe malaria, representing the largest ongoing genome-wide association study of an infectious disease. In December 2011 we completed genotyping of &amp;gt;1 million SNPs on &amp;gt;20,000 individuals from 10 different populations.</gtr:impact><gtr:outcomeId>EJCE3jdbkTJ-17</gtr:outcomeId><gtr:partnerContribution>MalariaGEN - the Malaria Genomic Epidemiology Network - is a community of more than 100 researchers in 30 countries, working together on projects that require sharing and integration of large amounts of data.

MalariaGEN brings together the work of many different partner studies, each of which is led by an independent investigator and has its own scientific objectives. MalariaGEN adds value to partner studies by providing access to genotyping and sequencing technologies, and by providing a framework for sharing and integrating data in consortial and community projects. 

MalariaGEN provides training and support in genetic data analysis for researchers at partner institutions in malaria-endemic countries. We do this through a data bursary scheme and through an active programme of scientific meetings and training workshops. These activities are supported by the MalariaGEN Resource Centre which has a team of experts in statistics, population genetics and bioinformatics at the Sanger Institute, Oxford University, the London School of Hygiene and Tropical Medicine, and Mahidol University in Bangkok.

There are many practical and ethical challenges involved in sharing data across a global network comprising investigators and institutions with great disparities in funding and infrastructure. The MalariaGEN community has been working to develop transparent procedures for ethics and governance. We have a governance committee and an independent data access committee, and network policies have been defined for data sharing and data access.</gtr:partnerContribution><gtr:piContribution>I direct the MalariaGEN Resource Centre (http://www.malariagen.net/). CGGH supports Resource Centre activities, particularly statistics, software engineering, and ethics.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Buea</gtr:collaboratingOrganisation><gtr:country>Cameroon, Republic of</gtr:country><gtr:description>Malaria Genomic Epidemiology Network (MalariaGEN)</gtr:description><gtr:id>A32C78EE-DB9F-43CE-84E0-49100A3F3F63</gtr:id><gtr:impact>See www.malariagen.net. Outputs are given in more detail in G0600718B. They include the development of the major global repository of samples and data for genomic epidemiology studies of malaria; and large-scale GWAS and genome sequencing data generation for host, parasite and vector.

Examples relevant to this grant:
1. The world's largest repository of DNA samples and clinical data for genetic studies of host-parasite interactions in malaria
2. Publication of the first genome-wide association study of human disease susceptibility in Africa
3. A large multicentre case-control study of severe malaria, representing the largest ongoing genome-wide association study of an infectious disease. In December 2011 we completed genotyping of &amp;gt;1 million SNPs on &amp;gt;20,000 individuals from 10 different populations.</gtr:impact><gtr:outcomeId>EJCE3jdbkTJ-9</gtr:outcomeId><gtr:partnerContribution>MalariaGEN - the Malaria Genomic Epidemiology Network - is a community of more than 100 researchers in 30 countries, working together on projects that require sharing and integration of large amounts of data.

MalariaGEN brings together the work of many different partner studies, each of which is led by an independent investigator and has its own scientific objectives. MalariaGEN adds value to partner studies by providing access to genotyping and sequencing technologies, and by providing a framework for sharing and integrating data in consortial and community projects. 

MalariaGEN provides training and support in genetic data analysis for researchers at partner institutions in malaria-endemic countries. We do this through a data bursary scheme and through an active programme of scientific meetings and training workshops. These activities are supported by the MalariaGEN Resource Centre which has a team of experts in statistics, population genetics and bioinformatics at the Sanger Institute, Oxford University, the London School of Hygiene and Tropical Medicine, and Mahidol University in Bangkok.

There are many practical and ethical challenges involved in sharing data across a global network comprising investigators and institutions with great disparities in funding and infrastructure. The MalariaGEN community has been working to develop transparent procedures for ethics and governance. We have a governance committee and an independent data access committee, and network policies have been defined for data sharing and data access.</gtr:partnerContribution><gtr:piContribution>I direct the MalariaGEN Resource Centre (http://www.malariagen.net/). CGGH supports Resource Centre activities, particularly statistics, software engineering, and ethics.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Menzies School of Health Research</gtr:collaboratingOrganisation><gtr:country>Australia, Commonwealth of</gtr:country><gtr:description>WorldWide Antimalarial Resistance Network</gtr:description><gtr:id>B8A85108-5E01-4C53-9D2D-1B489014403E</gtr:id><gtr:impact>The following points outline some of the key outputs that have resulted.

Developed and deployed a data submission system that accepts clinical, molecular, pharmacological and in vitro data in any format.

Designed and built a a sophisticated data repository that stores and connects the different types of data.

Built an interactive tool, WWARN Explorer to visualise data relating to antimalarial resistance.

Designed and developed the Molecular Surveyor, an interactive map summarising the location and incidence of molecular markers of sulphadoxine pyrimethamine resistance in Plasmodium falciparum dhfr and dhps genes compiled from peer-reviewed publications. 

Designed and developed the Antimalarial Quality (AQ) Surveyor, a data visualisation tool that tabulates and maps reports of antimalarial quality with summary data for individual surveys.

Led the initial design and hosting for the WWARN website.</gtr:impact><gtr:outcomeId>608DB7C6871-5</gtr:outcomeId><gtr:partnerContribution>WWARN provides high-quality data resources, customised research tools and services, and a global platform for exchanging scientific and public health information on malaria drug resistance. Since its formation WWARN has grown into a multidisciplinary, global data sharing network with more than 150 collaborators, bringing together researchers, clinicians, and public health professionals.</gtr:partnerContribution><gtr:piContribution>As the Head of Informatics, I provide leadership to the team developing the open-source, web-based informatics tools that underpin WWARN's data sharing and analysis, as well as providing data visualisations that make core findings available open access. This builds on work funded by a previous MRC grant that contributed to the Topheno web application for integration of clinical and epidemiological data across global research networks.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Pasteur Institute Dakar</gtr:collaboratingOrganisation><gtr:country>Senegal, Republic of</gtr:country><gtr:description>Malaria Genomic Epidemiology Network (MalariaGEN)</gtr:description><gtr:id>4CD958E2-366B-45C6-AA7F-94F2DF4C4C1C</gtr:id><gtr:impact>See www.malariagen.net. Outputs are given in more detail in G0600718B. They include the development of the major global repository of samples and data for genomic epidemiology studies of malaria; and large-scale GWAS and genome sequencing data generation for host, parasite and vector.

Examples relevant to this grant:
1. The world's largest repository of DNA samples and clinical data for genetic studies of host-parasite interactions in malaria
2. Publication of the first genome-wide association study of human disease susceptibility in Africa
3. A large multicentre case-control study of severe malaria, representing the largest ongoing genome-wide association study of an infectious disease. In December 2011 we completed genotyping of &amp;gt;1 million SNPs on &amp;gt;20,000 individuals from 10 different populations.</gtr:impact><gtr:outcomeId>EJCE3jdbkTJ-8</gtr:outcomeId><gtr:partnerContribution>MalariaGEN - the Malaria Genomic Epidemiology Network - is a community of more than 100 researchers in 30 countries, working together on projects that require sharing and integration of large amounts of data.

MalariaGEN brings together the work of many different partner studies, each of which is led by an independent investigator and has its own scientific objectives. MalariaGEN adds value to partner studies by providing access to genotyping and sequencing technologies, and by providing a framework for sharing and integrating data in consortial and community projects. 

MalariaGEN provides training and support in genetic data analysis for researchers at partner institutions in malaria-endemic countries. We do this through a data bursary scheme and through an active programme of scientific meetings and training workshops. These activities are supported by the MalariaGEN Resource Centre which has a team of experts in statistics, population genetics and bioinformatics at the Sanger Institute, Oxford University, the London School of Hygiene and Tropical Medicine, and Mahidol University in Bangkok.

There are many practical and ethical challenges involved in sharing data across a global network comprising investigators and institutions with great disparities in funding and infrastructure. The MalariaGEN community has been working to develop transparent procedures for ethics and governance. We have a governance committee and an independent data access committee, and network policies have been defined for data sharing and data access.</gtr:partnerContribution><gtr:piContribution>I direct the MalariaGEN Resource Centre (http://www.malariagen.net/). CGGH supports Resource Centre activities, particularly statistics, software engineering, and ethics.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>Vietnam, Socialist Republic of</gtr:country><gtr:department>Oxford University Clinical Research Unit Vietnam (OUCRU)</gtr:department><gtr:description>Malaria Genomic Epidemiology Network (MalariaGEN)</gtr:description><gtr:id>3A5138BF-0D57-4833-A514-BA4EBB06265B</gtr:id><gtr:impact>See www.malariagen.net. Outputs are given in more detail in G0600718B. They include the development of the major global repository of samples and data for genomic epidemiology studies of malaria; and large-scale GWAS and genome sequencing data generation for host, parasite and vector.

Examples relevant to this grant:
1. The world's largest repository of DNA samples and clinical data for genetic studies of host-parasite interactions in malaria
2. Publication of the first genome-wide association study of human disease susceptibility in Africa
3. A large multicentre case-control study of severe malaria, representing the largest ongoing genome-wide association study of an infectious disease. In December 2011 we completed genotyping of &amp;gt;1 million SNPs on &amp;gt;20,000 individuals from 10 different populations.</gtr:impact><gtr:outcomeId>EJCE3jdbkTJ-16</gtr:outcomeId><gtr:partnerContribution>MalariaGEN - the Malaria Genomic Epidemiology Network - is a community of more than 100 researchers in 30 countries, working together on projects that require sharing and integration of large amounts of data.

MalariaGEN brings together the work of many different partner studies, each of which is led by an independent investigator and has its own scientific objectives. MalariaGEN adds value to partner studies by providing access to genotyping and sequencing technologies, and by providing a framework for sharing and integrating data in consortial and community projects. 

MalariaGEN provides training and support in genetic data analysis for researchers at partner institutions in malaria-endemic countries. We do this through a data bursary scheme and through an active programme of scientific meetings and training workshops. These activities are supported by the MalariaGEN Resource Centre which has a team of experts in statistics, population genetics and bioinformatics at the Sanger Institute, Oxford University, the London School of Hygiene and Tropical Medicine, and Mahidol University in Bangkok.

There are many practical and ethical challenges involved in sharing data across a global network comprising investigators and institutions with great disparities in funding and infrastructure. The MalariaGEN community has been working to develop transparent procedures for ethics and governance. We have a governance committee and an independent data access committee, and network policies have been defined for data sharing and data access.</gtr:partnerContribution><gtr:piContribution>I direct the MalariaGEN Resource Centre (http://www.malariagen.net/). CGGH supports Resource Centre activities, particularly statistics, software engineering, and ethics.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cote D'Ivoire's National Institute of Public Health</gtr:collaboratingOrganisation><gtr:country>Cote d'Ivoire, Republic of</gtr:country><gtr:department>Malaria Research and Control Centre</gtr:department><gtr:description>Plasmodium Diversity Network Africa</gtr:description><gtr:id>59D53407-3A47-4671-8071-E21FD4CB94FB</gtr:id><gtr:impact>Since established there are two PDNA led publications and &amp;pound;5m grant funding through the Wellcome Trust Developing Excellence in Leadership, Training and Science Initiative.</gtr:impact><gtr:outcomeId>hobsd8mnVn4-11</gtr:outcomeId><gtr:partnerContribution>The Plasmodium Diversity Network Africa (PDNA) is a partnership of African scientists working together to determine the diversity of the malaria parasite in sub-Saharan Africa and by using this data, inform malaria control policy. PDNA members are leading research programmes in their own contexts and are part of the training and capacity development of early career African scientists.</gtr:partnerContribution><gtr:piContribution>CGGH has provided small starter grants to PDNA, in part by MRC Centenary Award, as part of our mission to support the training and capacity development of early career African scientists. CGGH continues to support PDNA is various ways including supporting training and providing mentor ship.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Wellcome Trust Sanger Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Malaria Genomic Epidemiology Network (MalariaGEN)</gtr:description><gtr:id>BF6D742D-BDC0-448F-9ABD-7C988E1654A5</gtr:id><gtr:impact>See www.malariagen.net. Outputs are given in more detail in G0600718B. They include the development of the major global repository of samples and data for genomic epidemiology studies of malaria; and large-scale GWAS and genome sequencing data generation for host, parasite and vector.

Examples relevant to this grant:
1. The world's largest repository of DNA samples and clinical data for genetic studies of host-parasite interactions in malaria
2. Publication of the first genome-wide association study of human disease susceptibility in Africa
3. A large multicentre case-control study of severe malaria, representing the largest ongoing genome-wide association study of an infectious disease. In December 2011 we completed genotyping of &amp;gt;1 million SNPs on &amp;gt;20,000 individuals from 10 different populations.</gtr:impact><gtr:outcomeId>EJCE3jdbkTJ-4</gtr:outcomeId><gtr:partnerContribution>MalariaGEN - the Malaria Genomic Epidemiology Network - is a community of more than 100 researchers in 30 countries, working together on projects that require sharing and integration of large amounts of data.

MalariaGEN brings together the work of many different partner studies, each of which is led by an independent investigator and has its own scientific objectives. MalariaGEN adds value to partner studies by providing access to genotyping and sequencing technologies, and by providing a framework for sharing and integrating data in consortial and community projects. 

MalariaGEN provides training and support in genetic data analysis for researchers at partner institutions in malaria-endemic countries. We do this through a data bursary scheme and through an active programme of scientific meetings and training workshops. These activities are supported by the MalariaGEN Resource Centre which has a team of experts in statistics, population genetics and bioinformatics at the Sanger Institute, Oxford University, the London School of Hygiene and Tropical Medicine, and Mahidol University in Bangkok.

There are many practical and ethical challenges involved in sharing data across a global network comprising investigators and institutions with great disparities in funding and infrastructure. The MalariaGEN community has been working to develop transparent procedures for ethics and governance. We have a governance committee and an independent data access committee, and network policies have been defined for data sharing and data access.</gtr:partnerContribution><gtr:piContribution>I direct the MalariaGEN Resource Centre (http://www.malariagen.net/). CGGH supports Resource Centre activities, particularly statistics, software engineering, and ethics.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Wellcome Trust Sanger Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>UKCRC Modernising Medical Microbiology consortium</gtr:description><gtr:id>693DAF15-6F42-4012-A50F-2778C9E69A29</gtr:id><gtr:impact>Web application is in development</gtr:impact><gtr:outcomeId>46F14275723-2</gtr:outcomeId><gtr:partnerContribution>See above</gtr:partnerContribution><gtr:piContribution>We have contributed to the development of web informatics tools for the Modernising Medical Microbiology Consortium. This follows on from work funded by this MRC grant to develop the MapSeq web application for population-level analysis of genome variation in parasites and pathogens.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>Gambia, Republic of the</gtr:country><gtr:department>MRC Unit, The Gambia</gtr:department><gtr:description>Malaria Genomic Epidemiology Network (MalariaGEN)</gtr:description><gtr:id>4F493DD1-7E01-4E78-ADCB-1DBC03A9AB1A</gtr:id><gtr:impact>See www.malariagen.net. Outputs are given in more detail in G0600718B. They include the development of the major global repository of samples and data for genomic epidemiology studies of malaria; and large-scale GWAS and genome sequencing data generation for host, parasite and vector.

Examples relevant to this grant:
1. The world's largest repository of DNA samples and clinical data for genetic studies of host-parasite interactions in malaria
2. Publication of the first genome-wide association study of human disease susceptibility in Africa
3. A large multicentre case-control study of severe malaria, representing the largest ongoing genome-wide association study of an infectious disease. In December 2011 we completed genotyping of &amp;gt;1 million SNPs on &amp;gt;20,000 individuals from 10 different populations.</gtr:impact><gtr:outcomeId>EJCE3jdbkTJ-5</gtr:outcomeId><gtr:partnerContribution>MalariaGEN - the Malaria Genomic Epidemiology Network - is a community of more than 100 researchers in 30 countries, working together on projects that require sharing and integration of large amounts of data.

MalariaGEN brings together the work of many different partner studies, each of which is led by an independent investigator and has its own scientific objectives. MalariaGEN adds value to partner studies by providing access to genotyping and sequencing technologies, and by providing a framework for sharing and integrating data in consortial and community projects. 

MalariaGEN provides training and support in genetic data analysis for researchers at partner institutions in malaria-endemic countries. We do this through a data bursary scheme and through an active programme of scientific meetings and training workshops. These activities are supported by the MalariaGEN Resource Centre which has a team of experts in statistics, population genetics and bioinformatics at the Sanger Institute, Oxford University, the London School of Hygiene and Tropical Medicine, and Mahidol University in Bangkok.

There are many practical and ethical challenges involved in sharing data across a global network comprising investigators and institutions with great disparities in funding and infrastructure. The MalariaGEN community has been working to develop transparent procedures for ethics and governance. We have a governance committee and an independent data access committee, and network policies have been defined for data sharing and data access.</gtr:partnerContribution><gtr:piContribution>I direct the MalariaGEN Resource Centre (http://www.malariagen.net/). CGGH supports Resource Centre activities, particularly statistics, software engineering, and ethics.</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>Gambia, Republic of the</gtr:country><gtr:department>MRC Unit, The Gambia</gtr:department><gtr:description>Plasmodium Diversity Network Africa</gtr:description><gtr:id>08D55617-42C9-4930-A4E2-F763C22B0899</gtr:id><gtr:impact>Since established there are two PDNA led publications and &amp;pound;5m grant funding through the Wellcome Trust Developing Excellence in Leadership, Training and Science Initiative.</gtr:impact><gtr:outcomeId>hobsd8mnVn4-6</gtr:outcomeId><gtr:partnerContribution>The Plasmodium Diversity Network Africa (PDNA) is a partnership of African scientists working together to determine the diversity of the malaria parasite in sub-Saharan Africa and by using this data, inform malaria control policy. PDNA members are leading research programmes in their own contexts and are part of the training and capacity development of early career African scientists.</gtr:partnerContribution><gtr:piContribution>CGGH has provided small starter grants to PDNA, in part by MRC Centenary Award, as part of our mission to support the training and capacity development of early career African scientists. CGGH continues to support PDNA is various ways including supporting training and providing mentor ship.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>London School of Hygiene and Tropical Medicine (LSHTM)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Malaria Genomic Epidemiology Network (MalariaGEN)</gtr:description><gtr:id>B3B43E93-1C30-4880-BB86-580E811ACDCE</gtr:id><gtr:impact>See www.malariagen.net. Outputs are given in more detail in G0600718B. They include the development of the major global repository of samples and data for genomic epidemiology studies of malaria; and large-scale GWAS and genome sequencing data generation for host, parasite and vector.

Examples relevant to this grant:
1. The world's largest repository of DNA samples and clinical data for genetic studies of host-parasite interactions in malaria
2. Publication of the first genome-wide association study of human disease susceptibility in Africa
3. A large multicentre case-control study of severe malaria, representing the largest ongoing genome-wide association study of an infectious disease. In December 2011 we completed genotyping of &amp;gt;1 million SNPs on &amp;gt;20,000 individuals from 10 different populations.</gtr:impact><gtr:outcomeId>EJCE3jdbkTJ-2</gtr:outcomeId><gtr:partnerContribution>MalariaGEN - the Malaria Genomic Epidemiology Network - is a community of more than 100 researchers in 30 countries, working together on projects that require sharing and integration of large amounts of data.

MalariaGEN brings together the work of many different partner studies, each of which is led by an independent investigator and has its own scientific objectives. MalariaGEN adds value to partner studies by providing access to genotyping and sequencing technologies, and by providing a framework for sharing and integrating data in consortial and community projects. 

MalariaGEN provides training and support in genetic data analysis for researchers at partner institutions in malaria-endemic countries. We do this through a data bursary scheme and through an active programme of scientific meetings and training workshops. These activities are supported by the MalariaGEN Resource Centre which has a team of experts in statistics, population genetics and bioinformatics at the Sanger Institute, Oxford University, the London School of Hygiene and Tropical Medicine, and Mahidol University in Bangkok.

There are many practical and ethical challenges involved in sharing data across a global network comprising investigators and institutions with great disparities in funding and infrastructure. The MalariaGEN community has been working to develop transparent procedures for ethics and governance. We have a governance committee and an independent data access committee, and network policies have been defined for data sharing and data access.</gtr:partnerContribution><gtr:piContribution>I direct the MalariaGEN Resource Centre (http://www.malariagen.net/). CGGH supports Resource Centre activities, particularly statistics, software engineering, and ethics.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Stockholm University</gtr:collaboratingOrganisation><gtr:country>Sweden, Kingdom of</gtr:country><gtr:description>Malaria Genomic Epidemiology Network (MalariaGEN)</gtr:description><gtr:id>A27F69CF-50D3-48BF-9673-D828AD0BE4A8</gtr:id><gtr:impact>See www.malariagen.net. Outputs are given in more detail in G0600718B. They include the development of the major global repository of samples and data for genomic epidemiology studies of malaria; and large-scale GWAS and genome sequencing data generation for host, parasite and vector.

Examples relevant to this grant:
1. The world's largest repository of DNA samples and clinical data for genetic studies of host-parasite interactions in malaria
2. Publication of the first genome-wide association study of human disease susceptibility in Africa
3. A large multicentre case-control study of severe malaria, representing the largest ongoing genome-wide association study of an infectious disease. In December 2011 we completed genotyping of &amp;gt;1 million SNPs on &amp;gt;20,000 individuals from 10 different populations.</gtr:impact><gtr:outcomeId>EJCE3jdbkTJ-23</gtr:outcomeId><gtr:partnerContribution>MalariaGEN - the Malaria Genomic Epidemiology Network - is a community of more than 100 researchers in 30 countries, working together on projects that require sharing and integration of large amounts of data.

MalariaGEN brings together the work of many different partner studies, each of which is led by an independent investigator and has its own scientific objectives. MalariaGEN adds value to partner studies by providing access to genotyping and sequencing technologies, and by providing a framework for sharing and integrating data in consortial and community projects. 

MalariaGEN provides training and support in genetic data analysis for researchers at partner institutions in malaria-endemic countries. We do this through a data bursary scheme and through an active programme of scientific meetings and training workshops. These activities are supported by the MalariaGEN Resource Centre which has a team of experts in statistics, population genetics and bioinformatics at the Sanger Institute, Oxford University, the London School of Hygiene and Tropical Medicine, and Mahidol University in Bangkok.

There are many practical and ethical challenges involved in sharing data across a global network comprising investigators and institutions with great disparities in funding and infrastructure. The MalariaGEN community has been working to develop transparent procedures for ethics and governance. We have a governance committee and an independent data access committee, and network policies have been defined for data sharing and data access.</gtr:partnerContribution><gtr:piContribution>I direct the MalariaGEN Resource Centre (http://www.malariagen.net/). CGGH supports Resource Centre activities, particularly statistics, software engineering, and ethics.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Noguchi Memorial Institute for Medical Research (NMRR)</gtr:collaboratingOrganisation><gtr:country>Ghana, Republic of</gtr:country><gtr:description>Plasmodium Diversity Network Africa</gtr:description><gtr:id>C144E8B4-41A7-4287-B7AE-0D7D70DDB8C5</gtr:id><gtr:impact>Since established there are two PDNA led publications and &amp;pound;5m grant funding through the Wellcome Trust Developing Excellence in Leadership, Training and Science Initiative.</gtr:impact><gtr:outcomeId>hobsd8mnVn4-5</gtr:outcomeId><gtr:partnerContribution>The Plasmodium Diversity Network Africa (PDNA) is a partnership of African scientists working together to determine the diversity of the malaria parasite in sub-Saharan Africa and by using this data, inform malaria control policy. PDNA members are leading research programmes in their own contexts and are part of the training and capacity development of early career African scientists.</gtr:partnerContribution><gtr:piContribution>CGGH has provided small starter grants to PDNA, in part by MRC Centenary Award, as part of our mission to support the training and capacity development of early career African scientists. CGGH continues to support PDNA is various ways including supporting training and providing mentor ship.</gtr:piContribution><gtr:sector>Learned Society</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Oxford University Hospitals NHS Foundation Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>UKCRC Modernising Medical Microbiology consortium</gtr:description><gtr:id>C82D7EDA-CE46-4648-9F46-FEF6E24AA36A</gtr:id><gtr:impact>Web application is in development</gtr:impact><gtr:outcomeId>46F14275723-3</gtr:outcomeId><gtr:partnerContribution>See above</gtr:partnerContribution><gtr:piContribution>We have contributed to the development of web informatics tools for the Modernising Medical Microbiology Consortium. This follows on from work funded by this MRC grant to develop the MapSeq web application for population-level analysis of genome variation in parasites and pathogens.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Wellcome Trust</gtr:collaboratingOrganisation><gtr:country>Kenya, Republic of</gtr:country><gtr:department>KEMRI-Wellcome Trust Research Programme</gtr:department><gtr:description>Malaria Genomic Epidemiology Network (MalariaGEN)</gtr:description><gtr:id>A44FA970-05EC-4B38-8C61-DC4EEEE084D6</gtr:id><gtr:impact>See www.malariagen.net. Outputs are given in more detail in G0600718B. They include the development of the major global repository of samples and data for genomic epidemiology studies of malaria; and large-scale GWAS and genome sequencing data generation for host, parasite and vector.

Examples relevant to this grant:
1. The world's largest repository of DNA samples and clinical data for genetic studies of host-parasite interactions in malaria
2. Publication of the first genome-wide association study of human disease susceptibility in Africa
3. A large multicentre case-control study of severe malaria, representing the largest ongoing genome-wide association study of an infectious disease. In December 2011 we completed genotyping of &amp;gt;1 million SNPs on &amp;gt;20,000 individuals from 10 different populations.</gtr:impact><gtr:outcomeId>EJCE3jdbkTJ-3</gtr:outcomeId><gtr:partnerContribution>MalariaGEN - the Malaria Genomic Epidemiology Network - is a community of more than 100 researchers in 30 countries, working together on projects that require sharing and integration of large amounts of data.

MalariaGEN brings together the work of many different partner studies, each of which is led by an independent investigator and has its own scientific objectives. MalariaGEN adds value to partner studies by providing access to genotyping and sequencing technologies, and by providing a framework for sharing and integrating data in consortial and community projects. 

MalariaGEN provides training and support in genetic data analysis for researchers at partner institutions in malaria-endemic countries. We do this through a data bursary scheme and through an active programme of scientific meetings and training workshops. These activities are supported by the MalariaGEN Resource Centre which has a team of experts in statistics, population genetics and bioinformatics at the Sanger Institute, Oxford University, the London School of Hygiene and Tropical Medicine, and Mahidol University in Bangkok.

There are many practical and ethical challenges involved in sharing data across a global network comprising investigators and institutions with great disparities in funding and infrastructure. The MalariaGEN community has been working to develop transparent procedures for ethics and governance. We have a governance committee and an independent data access committee, and network policies have been defined for data sharing and data access.</gtr:partnerContribution><gtr:piContribution>I direct the MalariaGEN Resource Centre (http://www.malariagen.net/). CGGH supports Resource Centre activities, particularly statistics, software engineering, and ethics.</gtr:piContribution><gtr:sector>Multiple</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Pasteur Institute, Paris</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:description>Malaria Genomic Epidemiology Network (MalariaGEN)</gtr:description><gtr:id>97B27198-D4A6-4BB8-B4C8-06D34D94C614</gtr:id><gtr:impact>See www.malariagen.net. Outputs are given in more detail in G0600718B. They include the development of the major global repository of samples and data for genomic epidemiology studies of malaria; and large-scale GWAS and genome sequencing data generation for host, parasite and vector.

Examples relevant to this grant:
1. The world's largest repository of DNA samples and clinical data for genetic studies of host-parasite interactions in malaria
2. Publication of the first genome-wide association study of human disease susceptibility in Africa
3. A large multicentre case-control study of severe malaria, representing the largest ongoing genome-wide association study of an infectious disease. In December 2011 we completed genotyping of &amp;gt;1 million SNPs on &amp;gt;20,000 individuals from 10 different populations.</gtr:impact><gtr:outcomeId>EJCE3jdbkTJ-6</gtr:outcomeId><gtr:partnerContribution>MalariaGEN - the Malaria Genomic Epidemiology Network - is a community of more than 100 researchers in 30 countries, working together on projects that require sharing and integration of large amounts of data.

MalariaGEN brings together the work of many different partner studies, each of which is led by an independent investigator and has its own scientific objectives. MalariaGEN adds value to partner studies by providing access to genotyping and sequencing technologies, and by providing a framework for sharing and integrating data in consortial and community projects. 

MalariaGEN provides training and support in genetic data analysis for researchers at partner institutions in malaria-endemic countries. We do this through a data bursary scheme and through an active programme of scientific meetings and training workshops. These activities are supported by the MalariaGEN Resource Centre which has a team of experts in statistics, population genetics and bioinformatics at the Sanger Institute, Oxford University, the London School of Hygiene and Tropical Medicine, and Mahidol University in Bangkok.

There are many practical and ethical challenges involved in sharing data across a global network comprising investigators and institutions with great disparities in funding and infrastructure. The MalariaGEN community has been working to develop transparent procedures for ethics and governance. We have a governance committee and an independent data access committee, and network policies have been defined for data sharing and data access.</gtr:partnerContribution><gtr:piContribution>I direct the MalariaGEN Resource Centre (http://www.malariagen.net/). CGGH supports Resource Centre activities, particularly statistics, software engineering, and ethics.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Washington</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>WorldWide Antimalarial Resistance Network</gtr:description><gtr:id>9D0F9912-58DA-424E-AECD-EDE5590C2739</gtr:id><gtr:impact>The following points outline some of the key outputs that have resulted.

Developed and deployed a data submission system that accepts clinical, molecular, pharmacological and in vitro data in any format.

Designed and built a a sophisticated data repository that stores and connects the different types of data.

Built an interactive tool, WWARN Explorer to visualise data relating to antimalarial resistance.

Designed and developed the Molecular Surveyor, an interactive map summarising the location and incidence of molecular markers of sulphadoxine pyrimethamine resistance in Plasmodium falciparum dhfr and dhps genes compiled from peer-reviewed publications. 

Designed and developed the Antimalarial Quality (AQ) Surveyor, a data visualisation tool that tabulates and maps reports of antimalarial quality with summary data for individual surveys.

Led the initial design and hosting for the WWARN website.</gtr:impact><gtr:outcomeId>608DB7C6871-2</gtr:outcomeId><gtr:partnerContribution>WWARN provides high-quality data resources, customised research tools and services, and a global platform for exchanging scientific and public health information on malaria drug resistance. Since its formation WWARN has grown into a multidisciplinary, global data sharing network with more than 150 collaborators, bringing together researchers, clinicians, and public health professionals.</gtr:partnerContribution><gtr:piContribution>As the Head of Informatics, I provide leadership to the team developing the open-source, web-based informatics tools that underpin WWARN's data sharing and analysis, as well as providing data visualisations that make core findings available open access. This builds on work funded by a previous MRC grant that contributed to the Topheno web application for integration of clinical and epidemiological data across global research networks.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Noguchi Memorial Institute for Medical Research (NMRR)</gtr:collaboratingOrganisation><gtr:country>Ghana, Republic of</gtr:country><gtr:description>Malaria Genomic Epidemiology Network (MalariaGEN)</gtr:description><gtr:id>795861B4-21A1-476D-8598-7842A3E6A722</gtr:id><gtr:impact>See www.malariagen.net. Outputs are given in more detail in G0600718B. They include the development of the major global repository of samples and data for genomic epidemiology studies of malaria; and large-scale GWAS and genome sequencing data generation for host, parasite and vector.

Examples relevant to this grant:
1. The world's largest repository of DNA samples and clinical data for genetic studies of host-parasite interactions in malaria
2. Publication of the first genome-wide association study of human disease susceptibility in Africa
3. A large multicentre case-control study of severe malaria, representing the largest ongoing genome-wide association study of an infectious disease. In December 2011 we completed genotyping of &amp;gt;1 million SNPs on &amp;gt;20,000 individuals from 10 different populations.</gtr:impact><gtr:outcomeId>EJCE3jdbkTJ-11</gtr:outcomeId><gtr:partnerContribution>MalariaGEN - the Malaria Genomic Epidemiology Network - is a community of more than 100 researchers in 30 countries, working together on projects that require sharing and integration of large amounts of data.

MalariaGEN brings together the work of many different partner studies, each of which is led by an independent investigator and has its own scientific objectives. MalariaGEN adds value to partner studies by providing access to genotyping and sequencing technologies, and by providing a framework for sharing and integrating data in consortial and community projects. 

MalariaGEN provides training and support in genetic data analysis for researchers at partner institutions in malaria-endemic countries. We do this through a data bursary scheme and through an active programme of scientific meetings and training workshops. These activities are supported by the MalariaGEN Resource Centre which has a team of experts in statistics, population genetics and bioinformatics at the Sanger Institute, Oxford University, the London School of Hygiene and Tropical Medicine, and Mahidol University in Bangkok.

There are many practical and ethical challenges involved in sharing data across a global network comprising investigators and institutions with great disparities in funding and infrastructure. The MalariaGEN community has been working to develop transparent procedures for ethics and governance. We have a governance committee and an independent data access committee, and network policies have been defined for data sharing and data access.</gtr:partnerContribution><gtr:piContribution>I direct the MalariaGEN Resource Centre (http://www.malariagen.net/). CGGH supports Resource Centre activities, particularly statistics, software engineering, and ethics.</gtr:piContribution><gtr:sector>Learned Society</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Addis Ababa University</gtr:collaboratingOrganisation><gtr:country>Ethiopia, Federal Democratic Republic of</gtr:country><gtr:department>Aklilu Lemma Institute of Pathobiology</gtr:department><gtr:description>Plasmodium Diversity Network Africa</gtr:description><gtr:id>B59DD1A0-9A2B-40EA-8E1A-85742928E7E3</gtr:id><gtr:impact>Since established there are two PDNA led publications and &amp;pound;5m grant funding through the Wellcome Trust Developing Excellence in Leadership, Training and Science Initiative.</gtr:impact><gtr:outcomeId>hobsd8mnVn4-8</gtr:outcomeId><gtr:partnerContribution>The Plasmodium Diversity Network Africa (PDNA) is a partnership of African scientists working together to determine the diversity of the malaria parasite in sub-Saharan Africa and by using this data, inform malaria control policy. PDNA members are leading research programmes in their own contexts and are part of the training and capacity development of early career African scientists.</gtr:partnerContribution><gtr:piContribution>CGGH has provided small starter grants to PDNA, in part by MRC Centenary Award, as part of our mission to support the training and capacity development of early career African scientists. CGGH continues to support PDNA is various ways including supporting training and providing mentor ship.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Universit? des Sciences de la Sant?, Gabon</gtr:collaboratingOrganisation><gtr:country>Gabon, Gabonese Republic</gtr:country><gtr:description>Plasmodium Diversity Network Africa</gtr:description><gtr:id>2CCE8AD8-7413-4167-A826-FC946B5BB6A4</gtr:id><gtr:impact>Since established there are two PDNA led publications and &amp;pound;5m grant funding through the Wellcome Trust Developing Excellence in Leadership, Training and Science Initiative.</gtr:impact><gtr:outcomeId>hobsd8mnVn4-9</gtr:outcomeId><gtr:partnerContribution>The Plasmodium Diversity Network Africa (PDNA) is a partnership of African scientists working together to determine the diversity of the malaria parasite in sub-Saharan Africa and by using this data, inform malaria control policy. PDNA members are leading research programmes in their own contexts and are part of the training and capacity development of early career African scientists.</gtr:partnerContribution><gtr:piContribution>CGGH has provided small starter grants to PDNA, in part by MRC Centenary Award, as part of our mission to support the training and capacity development of early career African scientists. CGGH continues to support PDNA is various ways including supporting training and providing mentor ship.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Nuffield Department of Clinical Medicine</gtr:department><gtr:description>UKCRC Modernising Medical Microbiology consortium</gtr:description><gtr:id>39C4E869-4473-423D-BC0B-0FCEACBCEA91</gtr:id><gtr:impact>Web application is in development</gtr:impact><gtr:outcomeId>46F14275723-1</gtr:outcomeId><gtr:partnerContribution>See above</gtr:partnerContribution><gtr:piContribution>We have contributed to the development of web informatics tools for the Modernising Medical Microbiology Consortium. This follows on from work funded by this MRC grant to develop the MapSeq web application for population-level analysis of genome variation in parasites and pathogens.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>World Health Organization (WHO)</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>WorldWide Antimalarial Resistance Network</gtr:description><gtr:id>F7CB43A1-28D6-43DD-8A3A-F262E4E564F9</gtr:id><gtr:impact>The following points outline some of the key outputs that have resulted.

Developed and deployed a data submission system that accepts clinical, molecular, pharmacological and in vitro data in any format.

Designed and built a a sophisticated data repository that stores and connects the different types of data.

Built an interactive tool, WWARN Explorer to visualise data relating to antimalarial resistance.

Designed and developed the Molecular Surveyor, an interactive map summarising the location and incidence of molecular markers of sulphadoxine pyrimethamine resistance in Plasmodium falciparum dhfr and dhps genes compiled from peer-reviewed publications. 

Designed and developed the Antimalarial Quality (AQ) Surveyor, a data visualisation tool that tabulates and maps reports of antimalarial quality with summary data for individual surveys.

Led the initial design and hosting for the WWARN website.</gtr:impact><gtr:outcomeId>608DB7C6871-6</gtr:outcomeId><gtr:partnerContribution>WWARN provides high-quality data resources, customised research tools and services, and a global platform for exchanging scientific and public health information on malaria drug resistance. Since its formation WWARN has grown into a multidisciplinary, global data sharing network with more than 150 collaborators, bringing together researchers, clinicians, and public health professionals.</gtr:partnerContribution><gtr:piContribution>As the Head of Informatics, I provide leadership to the team developing the open-source, web-based informatics tools that underpin WWARN's data sharing and analysis, as well as providing data visualisations that make core findings available open access. This builds on work funded by a previous MRC grant that contributed to the Topheno web application for integration of clinical and epidemiological data across global research networks.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Wellcome Trust</gtr:collaboratingOrganisation><gtr:country>Thailand, Kingdom of</gtr:country><gtr:department>Mahidol University-Oxford Tropical Medicine Research Programme</gtr:department><gtr:description>Tracking Resistance to Artemisinin Collaboration</gtr:description><gtr:id>64F79085-7B9A-472D-B72F-D3A9FABE57B5</gtr:id><gtr:impact>This project is at an early stage. We have already released genome sequence data on 1000 P. falciparum samples.</gtr:impact><gtr:outcomeId>Hf7BzvWgHyD-1</gtr:outcomeId><gtr:partnerContribution>see above</gtr:partnerContribution><gtr:piContribution>The TRAC (Tracking Resistance to Artemisinins Collaboration) study is coordinating prospective clinical and parasitological studies to assess artemisinin susceptibility in 1500 patients in 15 sites across Asia and Africa. This series of studies will provide well characterized malaria parasites with defined parasite clearance profiles for laboratory and molecular characterization, giving us a unique opportunity to identify a molecular marker of artemisinin resistance and validate an accurate laboratory test to detect resistance. The MRC Centre for Genomics and Global Health is supporting TRAC to perform a genome-wide association study of genetic correlates of delayed parasite clearance, based on genome sequencing of parasites in clinical samples. Initial work is focusing on establishing systems to manage the hundreds of terabytes of raw sequence data generated by this project. Also implementing a process of discovering and validating novel SNPs and other forms of genome variation in these samples, primarily based on alignment to the P.falciparum reference genome but also employing new methods of de-novo genome assembly that are currently under development. Having constructed a comprehensive catalogue of both novel and previously-reported variants, we will carry out genotyping of each sample, using statistical methods for quality assurance that have been validated using independent benchmarks. Having determined genotypes for each sample, we will carry out analyses of genetic association with the clinical phenotype. The aim of this project is that the results will be shared with the research community through user-friendly web tools that will allow scientists and public health authorities to navigate the massive quantities of information generated by the TRAC project.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Nuffield Department of Clinical Medicine</gtr:department><gtr:description>WorldWide Antimalarial Resistance Network</gtr:description><gtr:id>D8B1264B-D4A7-4FE9-8927-EA637B600ADE</gtr:id><gtr:impact>The following points outline some of the key outputs that have resulted.

Developed and deployed a data submission system that accepts clinical, molecular, pharmacological and in vitro data in any format.

Designed and built a a sophisticated data repository that stores and connects the different types of data.

Built an interactive tool, WWARN Explorer to visualise data relating to antimalarial resistance.

Designed and developed the Molecular Surveyor, an interactive map summarising the location and incidence of molecular markers of sulphadoxine pyrimethamine resistance in Plasmodium falciparum dhfr and dhps genes compiled from peer-reviewed publications. 

Designed and developed the Antimalarial Quality (AQ) Surveyor, a data visualisation tool that tabulates and maps reports of antimalarial quality with summary data for individual surveys.

Led the initial design and hosting for the WWARN website.</gtr:impact><gtr:outcomeId>608DB7C6871-1</gtr:outcomeId><gtr:partnerContribution>WWARN provides high-quality data resources, customised research tools and services, and a global platform for exchanging scientific and public health information on malaria drug resistance. Since its formation WWARN has grown into a multidisciplinary, global data sharing network with more than 150 collaborators, bringing together researchers, clinicians, and public health professionals.</gtr:partnerContribution><gtr:piContribution>As the Head of Informatics, I provide leadership to the team developing the open-source, web-based informatics tools that underpin WWARN's data sharing and analysis, as well as providing data visualisations that make core findings available open access. This builds on work funded by a previous MRC grant that contributed to the Topheno web application for integration of clinical and epidemiological data across global research networks.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Michigan</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Malaria Genomic Epidemiology Network (MalariaGEN)</gtr:description><gtr:id>F182135F-8235-46C3-BCDA-B1FC2C630497</gtr:id><gtr:impact>See www.malariagen.net. Outputs are given in more detail in G0600718B. They include the development of the major global repository of samples and data for genomic epidemiology studies of malaria; and large-scale GWAS and genome sequencing data generation for host, parasite and vector.

Examples relevant to this grant:
1. The world's largest repository of DNA samples and clinical data for genetic studies of host-parasite interactions in malaria
2. Publication of the first genome-wide association study of human disease susceptibility in Africa
3. A large multicentre case-control study of severe malaria, representing the largest ongoing genome-wide association study of an infectious disease. In December 2011 we completed genotyping of &amp;gt;1 million SNPs on &amp;gt;20,000 individuals from 10 different populations.</gtr:impact><gtr:outcomeId>EJCE3jdbkTJ-13</gtr:outcomeId><gtr:partnerContribution>MalariaGEN - the Malaria Genomic Epidemiology Network - is a community of more than 100 researchers in 30 countries, working together on projects that require sharing and integration of large amounts of data.

MalariaGEN brings together the work of many different partner studies, each of which is led by an independent investigator and has its own scientific objectives. MalariaGEN adds value to partner studies by providing access to genotyping and sequencing technologies, and by providing a framework for sharing and integrating data in consortial and community projects. 

MalariaGEN provides training and support in genetic data analysis for researchers at partner institutions in malaria-endemic countries. We do this through a data bursary scheme and through an active programme of scientific meetings and training workshops. These activities are supported by the MalariaGEN Resource Centre which has a team of experts in statistics, population genetics and bioinformatics at the Sanger Institute, Oxford University, the London School of Hygiene and Tropical Medicine, and Mahidol University in Bangkok.

There are many practical and ethical challenges involved in sharing data across a global network comprising investigators and institutions with great disparities in funding and infrastructure. The MalariaGEN community has been working to develop transparent procedures for ethics and governance. We have a governance committee and an independent data access committee, and network policies have been defined for data sharing and data access.</gtr:partnerContribution><gtr:piContribution>I direct the MalariaGEN Resource Centre (http://www.malariagen.net/). CGGH supports Resource Centre activities, particularly statistics, software engineering, and ethics.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Public Health England</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>UKCRC Modernising Medical Microbiology consortium</gtr:description><gtr:id>EEFCB9EC-A350-4301-B17C-7AB327E01D2C</gtr:id><gtr:impact>Web application is in development</gtr:impact><gtr:outcomeId>46F14275723-4</gtr:outcomeId><gtr:partnerContribution>See above</gtr:partnerContribution><gtr:piContribution>We have contributed to the development of web informatics tools for the Modernising Medical Microbiology Consortium. This follows on from work funded by this MRC grant to develop the MapSeq web application for population-level analysis of genome variation in parasites and pathogens.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Maryland</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>WorldWide Antimalarial Resistance Network</gtr:description><gtr:id>2D8A7031-F679-4C79-8899-9B39D0E84079</gtr:id><gtr:impact>The following points outline some of the key outputs that have resulted.

Developed and deployed a data submission system that accepts clinical, molecular, pharmacological and in vitro data in any format.

Designed and built a a sophisticated data repository that stores and connects the different types of data.

Built an interactive tool, WWARN Explorer to visualise data relating to antimalarial resistance.

Designed and developed the Molecular Surveyor, an interactive map summarising the location and incidence of molecular markers of sulphadoxine pyrimethamine resistance in Plasmodium falciparum dhfr and dhps genes compiled from peer-reviewed publications. 

Designed and developed the Antimalarial Quality (AQ) Surveyor, a data visualisation tool that tabulates and maps reports of antimalarial quality with summary data for individual surveys.

Led the initial design and hosting for the WWARN website.</gtr:impact><gtr:outcomeId>608DB7C6871-4</gtr:outcomeId><gtr:partnerContribution>WWARN provides high-quality data resources, customised research tools and services, and a global platform for exchanging scientific and public health information on malaria drug resistance. Since its formation WWARN has grown into a multidisciplinary, global data sharing network with more than 150 collaborators, bringing together researchers, clinicians, and public health professionals.</gtr:partnerContribution><gtr:piContribution>As the Head of Informatics, I provide leadership to the team developing the open-source, web-based informatics tools that underpin WWARN's data sharing and analysis, as well as providing data visualisations that make core findings available open access. This builds on work funded by a previous MRC grant that contributed to the Topheno web application for integration of clinical and epidemiological data across global research networks.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Bamako</gtr:collaboratingOrganisation><gtr:country>Mali, Republic of</gtr:country><gtr:department>Malaria Research and Training Centre (MRTC) Bamako</gtr:department><gtr:description>Plasmodium Diversity Network Africa</gtr:description><gtr:id>336B8151-B7F4-406D-950C-509B9CBBE800</gtr:id><gtr:impact>Since established there are two PDNA led publications and &amp;pound;5m grant funding through the Wellcome Trust Developing Excellence in Leadership, Training and Science Initiative.</gtr:impact><gtr:outcomeId>hobsd8mnVn4-1</gtr:outcomeId><gtr:partnerContribution>The Plasmodium Diversity Network Africa (PDNA) is a partnership of African scientists working together to determine the diversity of the malaria parasite in sub-Saharan Africa and by using this data, inform malaria control policy. PDNA members are leading research programmes in their own contexts and are part of the training and capacity development of early career African scientists.</gtr:partnerContribution><gtr:piContribution>CGGH has provided small starter grants to PDNA, in part by MRC Centenary Award, as part of our mission to support the training and capacity development of early career African scientists. CGGH continues to support PDNA is various ways including supporting training and providing mentor ship.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Congo National Institute of Biomedical Research (Institut National de Recherche Biom?dicale)</gtr:collaboratingOrganisation><gtr:country>Congo, Democratic Republic of the</gtr:country><gtr:description>Plasmodium Diversity Network Africa</gtr:description><gtr:id>178B0076-8DA9-4084-9217-6E7446FB57AD</gtr:id><gtr:impact>Since established there are two PDNA led publications and &amp;pound;5m grant funding through the Wellcome Trust Developing Excellence in Leadership, Training and Science Initiative.</gtr:impact><gtr:outcomeId>hobsd8mnVn4-7</gtr:outcomeId><gtr:partnerContribution>The Plasmodium Diversity Network Africa (PDNA) is a partnership of African scientists working together to determine the diversity of the malaria parasite in sub-Saharan Africa and by using this data, inform malaria control policy. PDNA members are leading research programmes in their own contexts and are part of the training and capacity development of early career African scientists.</gtr:partnerContribution><gtr:piContribution>CGGH has provided small starter grants to PDNA, in part by MRC Centenary Award, as part of our mission to support the training and capacity development of early career African scientists. CGGH continues to support PDNA is various ways including supporting training and providing mentor ship.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Liverpool School of Tropical Medicine</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Malaria Genomic Epidemiology Network (MalariaGEN)</gtr:description><gtr:id>8CE44442-FB46-4BA9-94B2-7E9EBC635513</gtr:id><gtr:impact>See www.malariagen.net. Outputs are given in more detail in G0600718B. They include the development of the major global repository of samples and data for genomic epidemiology studies of malaria; and large-scale GWAS and genome sequencing data generation for host, parasite and vector.

Examples relevant to this grant:
1. The world's largest repository of DNA samples and clinical data for genetic studies of host-parasite interactions in malaria
2. Publication of the first genome-wide association study of human disease susceptibility in Africa
3. A large multicentre case-control study of severe malaria, representing the largest ongoing genome-wide association study of an infectious disease. In December 2011 we completed genotyping of &amp;gt;1 million SNPs on &amp;gt;20,000 individuals from 10 different populations.</gtr:impact><gtr:outcomeId>EJCE3jdbkTJ-18</gtr:outcomeId><gtr:partnerContribution>MalariaGEN - the Malaria Genomic Epidemiology Network - is a community of more than 100 researchers in 30 countries, working together on projects that require sharing and integration of large amounts of data.

MalariaGEN brings together the work of many different partner studies, each of which is led by an independent investigator and has its own scientific objectives. MalariaGEN adds value to partner studies by providing access to genotyping and sequencing technologies, and by providing a framework for sharing and integrating data in consortial and community projects. 

MalariaGEN provides training and support in genetic data analysis for researchers at partner institutions in malaria-endemic countries. We do this through a data bursary scheme and through an active programme of scientific meetings and training workshops. These activities are supported by the MalariaGEN Resource Centre which has a team of experts in statistics, population genetics and bioinformatics at the Sanger Institute, Oxford University, the London School of Hygiene and Tropical Medicine, and Mahidol University in Bangkok.

There are many practical and ethical challenges involved in sharing data across a global network comprising investigators and institutions with great disparities in funding and infrastructure. The MalariaGEN community has been working to develop transparent procedures for ethics and governance. We have a governance committee and an independent data access committee, and network policies have been defined for data sharing and data access.</gtr:partnerContribution><gtr:piContribution>I direct the MalariaGEN Resource Centre (http://www.malariagen.net/). CGGH supports Resource Centre activities, particularly statistics, software engineering, and ethics.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Mahidol University</gtr:collaboratingOrganisation><gtr:country>Thailand, Kingdom of</gtr:country><gtr:description>Malaria Genomic Epidemiology Network (MalariaGEN)</gtr:description><gtr:id>C564E9CD-EC5B-429F-96B2-2F5E4C073DE8</gtr:id><gtr:impact>See www.malariagen.net. Outputs are given in more detail in G0600718B. They include the development of the major global repository of samples and data for genomic epidemiology studies of malaria; and large-scale GWAS and genome sequencing data generation for host, parasite and vector.

Examples relevant to this grant:
1. The world's largest repository of DNA samples and clinical data for genetic studies of host-parasite interactions in malaria
2. Publication of the first genome-wide association study of human disease susceptibility in Africa
3. A large multicentre case-control study of severe malaria, representing the largest ongoing genome-wide association study of an infectious disease. In December 2011 we completed genotyping of &amp;gt;1 million SNPs on &amp;gt;20,000 individuals from 10 different populations.</gtr:impact><gtr:outcomeId>EJCE3jdbkTJ-7</gtr:outcomeId><gtr:partnerContribution>MalariaGEN - the Malaria Genomic Epidemiology Network - is a community of more than 100 researchers in 30 countries, working together on projects that require sharing and integration of large amounts of data.

MalariaGEN brings together the work of many different partner studies, each of which is led by an independent investigator and has its own scientific objectives. MalariaGEN adds value to partner studies by providing access to genotyping and sequencing technologies, and by providing a framework for sharing and integrating data in consortial and community projects. 

MalariaGEN provides training and support in genetic data analysis for researchers at partner institutions in malaria-endemic countries. We do this through a data bursary scheme and through an active programme of scientific meetings and training workshops. These activities are supported by the MalariaGEN Resource Centre which has a team of experts in statistics, population genetics and bioinformatics at the Sanger Institute, Oxford University, the London School of Hygiene and Tropical Medicine, and Mahidol University in Bangkok.

There are many practical and ethical challenges involved in sharing data across a global network comprising investigators and institutions with great disparities in funding and infrastructure. The MalariaGEN community has been working to develop transparent procedures for ethics and governance. We have a governance committee and an independent data access committee, and network policies have been defined for data sharing and data access.</gtr:partnerContribution><gtr:piContribution>I direct the MalariaGEN Resource Centre (http://www.malariagen.net/). CGGH supports Resource Centre activities, particularly statistics, software engineering, and ethics.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Wellcome Trust Sanger Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Wellcome Trust Sanger Institute</gtr:description><gtr:id>551F2609-9A51-42B3-89D2-6F27418262B6</gtr:id><gtr:impact>Examples relevant to this grant:
1. The world's largest repository of DNA samples and clinical data for genetic studies of host-parasite interactions in malaria
2. Publication of the first genome-wide association study of human disease susceptibility in Africa
3. A large multicentre case-control study of severe malaria, representing the largest ongoing genome-wide association study of an infectious disease. In December 2011 we completed genotyping of &amp;gt;1 million SNPs on &amp;gt;20,000 individuals from 10 different populations.</gtr:impact><gtr:outcomeId>dE6dfaLoRwL-1</gtr:outcomeId><gtr:partnerContribution>The Sanger Institute provides infrastructure, resources and expertise in large-scale genome sequencing, genome-wide SNP typing, informatics and functional genomics.</gtr:partnerContribution><gtr:piContribution>As head of the Malaria Programme and the Global Health Strategy Group at the Sanger Institute, I'm engaged in all levels of work - scientific, strategic and operational.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Papua New Guinea Institute of Medical Research</gtr:collaboratingOrganisation><gtr:country>Papua New Guinea, Independent State of</gtr:country><gtr:description>Malaria Genomic Epidemiology Network (MalariaGEN)</gtr:description><gtr:id>798669D1-259A-4239-BBC9-3F9F15863D6C</gtr:id><gtr:impact>See www.malariagen.net. Outputs are given in more detail in G0600718B. They include the development of the major global repository of samples and data for genomic epidemiology studies of malaria; and large-scale GWAS and genome sequencing data generation for host, parasite and vector.

Examples relevant to this grant:
1. The world's largest repository of DNA samples and clinical data for genetic studies of host-parasite interactions in malaria
2. Publication of the first genome-wide association study of human disease susceptibility in Africa
3. A large multicentre case-control study of severe malaria, representing the largest ongoing genome-wide association study of an infectious disease. In December 2011 we completed genotyping of &amp;gt;1 million SNPs on &amp;gt;20,000 individuals from 10 different populations.</gtr:impact><gtr:outcomeId>EJCE3jdbkTJ-19</gtr:outcomeId><gtr:partnerContribution>MalariaGEN - the Malaria Genomic Epidemiology Network - is a community of more than 100 researchers in 30 countries, working together on projects that require sharing and integration of large amounts of data.

MalariaGEN brings together the work of many different partner studies, each of which is led by an independent investigator and has its own scientific objectives. MalariaGEN adds value to partner studies by providing access to genotyping and sequencing technologies, and by providing a framework for sharing and integrating data in consortial and community projects. 

MalariaGEN provides training and support in genetic data analysis for researchers at partner institutions in malaria-endemic countries. We do this through a data bursary scheme and through an active programme of scientific meetings and training workshops. These activities are supported by the MalariaGEN Resource Centre which has a team of experts in statistics, population genetics and bioinformatics at the Sanger Institute, Oxford University, the London School of Hygiene and Tropical Medicine, and Mahidol University in Bangkok.

There are many practical and ethical challenges involved in sharing data across a global network comprising investigators and institutions with great disparities in funding and infrastructure. The MalariaGEN community has been working to develop transparent procedures for ethics and governance. We have a governance committee and an independent data access committee, and network policies have been defined for data sharing and data access.</gtr:partnerContribution><gtr:piContribution>I direct the MalariaGEN Resource Centre (http://www.malariagen.net/). CGGH supports Resource Centre activities, particularly statistics, software engineering, and ethics.</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cape Town</gtr:collaboratingOrganisation><gtr:country>South Africa, Republic of</gtr:country><gtr:description>WorldWide Antimalarial Resistance Network</gtr:description><gtr:id>BBC2D480-6257-4328-8159-2533E039DBAD</gtr:id><gtr:impact>The following points outline some of the key outputs that have resulted.

Developed and deployed a data submission system that accepts clinical, molecular, pharmacological and in vitro data in any format.

Designed and built a a sophisticated data repository that stores and connects the different types of data.

Built an interactive tool, WWARN Explorer to visualise data relating to antimalarial resistance.

Designed and developed the Molecular Surveyor, an interactive map summarising the location and incidence of molecular markers of sulphadoxine pyrimethamine resistance in Plasmodium falciparum dhfr and dhps genes compiled from peer-reviewed publications. 

Designed and developed the Antimalarial Quality (AQ) Surveyor, a data visualisation tool that tabulates and maps reports of antimalarial quality with summary data for individual surveys.

Led the initial design and hosting for the WWARN website.</gtr:impact><gtr:outcomeId>608DB7C6871-3</gtr:outcomeId><gtr:partnerContribution>WWARN provides high-quality data resources, customised research tools and services, and a global platform for exchanging scientific and public health information on malaria drug resistance. Since its formation WWARN has grown into a multidisciplinary, global data sharing network with more than 150 collaborators, bringing together researchers, clinicians, and public health professionals.</gtr:partnerContribution><gtr:piContribution>As the Head of Informatics, I provide leadership to the team developing the open-source, web-based informatics tools that underpin WWARN's data sharing and analysis, as well as providing data visualisations that make core findings available open access. This builds on work funded by a previous MRC grant that contributed to the Topheno web application for integration of clinical and epidemiological data across global research networks.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Sapienza University of Rome</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:department>Parasitology Sapienza</gtr:department><gtr:description>Malaria Genomic Epidemiology Network (MalariaGEN)</gtr:description><gtr:id>FC968130-9648-47D5-AA5D-5CFDA402E8BE</gtr:id><gtr:impact>See www.malariagen.net. Outputs are given in more detail in G0600718B. They include the development of the major global repository of samples and data for genomic epidemiology studies of malaria; and large-scale GWAS and genome sequencing data generation for host, parasite and vector.

Examples relevant to this grant:
1. The world's largest repository of DNA samples and clinical data for genetic studies of host-parasite interactions in malaria
2. Publication of the first genome-wide association study of human disease susceptibility in Africa
3. A large multicentre case-control study of severe malaria, representing the largest ongoing genome-wide association study of an infectious disease. In December 2011 we completed genotyping of &amp;gt;1 million SNPs on &amp;gt;20,000 individuals from 10 different populations.</gtr:impact><gtr:outcomeId>EJCE3jdbkTJ-14</gtr:outcomeId><gtr:partnerContribution>MalariaGEN - the Malaria Genomic Epidemiology Network - is a community of more than 100 researchers in 30 countries, working together on projects that require sharing and integration of large amounts of data.

MalariaGEN brings together the work of many different partner studies, each of which is led by an independent investigator and has its own scientific objectives. MalariaGEN adds value to partner studies by providing access to genotyping and sequencing technologies, and by providing a framework for sharing and integrating data in consortial and community projects. 

MalariaGEN provides training and support in genetic data analysis for researchers at partner institutions in malaria-endemic countries. We do this through a data bursary scheme and through an active programme of scientific meetings and training workshops. These activities are supported by the MalariaGEN Resource Centre which has a team of experts in statistics, population genetics and bioinformatics at the Sanger Institute, Oxford University, the London School of Hygiene and Tropical Medicine, and Mahidol University in Bangkok.

There are many practical and ethical challenges involved in sharing data across a global network comprising investigators and institutions with great disparities in funding and infrastructure. The MalariaGEN community has been working to develop transparent procedures for ethics and governance. We have a governance committee and an independent data access committee, and network policies have been defined for data sharing and data access.</gtr:partnerContribution><gtr:piContribution>I direct the MalariaGEN Resource Centre (http://www.malariagen.net/). CGGH supports Resource Centre activities, particularly statistics, software engineering, and ethics.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Bamako</gtr:collaboratingOrganisation><gtr:country>Mali, Republic of</gtr:country><gtr:department>Malaria Research and Training Centre (MRTC) Bamako</gtr:department><gtr:description>Malaria Genomic Epidemiology Network (MalariaGEN)</gtr:description><gtr:id>B725D8F6-B542-4C37-9B1F-31F393CCE086</gtr:id><gtr:impact>See www.malariagen.net. Outputs are given in more detail in G0600718B. They include the development of the major global repository of samples and data for genomic epidemiology studies of malaria; and large-scale GWAS and genome sequencing data generation for host, parasite and vector.

Examples relevant to this grant:
1. The world's largest repository of DNA samples and clinical data for genetic studies of host-parasite interactions in malaria
2. Publication of the first genome-wide association study of human disease susceptibility in Africa
3. A large multicentre case-control study of severe malaria, representing the largest ongoing genome-wide association study of an infectious disease. In December 2011 we completed genotyping of &amp;gt;1 million SNPs on &amp;gt;20,000 individuals from 10 different populations.</gtr:impact><gtr:outcomeId>EJCE3jdbkTJ-1</gtr:outcomeId><gtr:partnerContribution>MalariaGEN - the Malaria Genomic Epidemiology Network - is a community of more than 100 researchers in 30 countries, working together on projects that require sharing and integration of large amounts of data.

MalariaGEN brings together the work of many different partner studies, each of which is led by an independent investigator and has its own scientific objectives. MalariaGEN adds value to partner studies by providing access to genotyping and sequencing technologies, and by providing a framework for sharing and integrating data in consortial and community projects. 

MalariaGEN provides training and support in genetic data analysis for researchers at partner institutions in malaria-endemic countries. We do this through a data bursary scheme and through an active programme of scientific meetings and training workshops. These activities are supported by the MalariaGEN Resource Centre which has a team of experts in statistics, population genetics and bioinformatics at the Sanger Institute, Oxford University, the London School of Hygiene and Tropical Medicine, and Mahidol University in Bangkok.

There are many practical and ethical challenges involved in sharing data across a global network comprising investigators and institutions with great disparities in funding and infrastructure. The MalariaGEN community has been working to develop transparent procedures for ethics and governance. We have a governance committee and an independent data access committee, and network policies have been defined for data sharing and data access.</gtr:partnerContribution><gtr:piContribution>I direct the MalariaGEN Resource Centre (http://www.malariagen.net/). CGGH supports Resource Centre activities, particularly statistics, software engineering, and ethics.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Various articles in popular media</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>A8805AA3-34A5-47DA-9D1C-F20D440F4689</gtr:id><gtr:impact>Our work has been featured in articles and news items in WIRED, Prospect and Scientific American

further media inquiries</gtr:impact><gtr:outcomeId>k9mMxccmcuD</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009,2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Radio</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>BB02B0A9-534D-4F06-B0F4-2A3F4D3259CB</gtr:id><gtr:impact>BBC World Service &amp;quot;The Age of the Genome&amp;quot;. Kwiatkowski interviewed by Richard Dawkins.

further media inquiries</gtr:impact><gtr:outcomeId>q1XgeNjc9SZ</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cambodia Manuscript Press Release</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>918A2C78-3D58-45D6-9853-0B18BF7B5A18</gtr:id><gtr:impact>A press release and associated follow up interviews led to media coverage of 64 stories in 13 languages (mostly in English, 78%); National coverage in 23 countries; High-profile coverage included Wired UK, BBC, The Guardian, FoxNews, AFP. Coverage on twitter included 12 tweets from accounts such as BBC World Service, Times of India, and Agence France Presse reached a combined following of 1.3 million users.

see above</gtr:impact><gtr:outcomeId>jYgb9TcdPeR</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>1956764</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Research Grant</gtr:description><gtr:end>2018-01-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/M006212/1</gtr:fundingRef><gtr:id>3517A06A-CE37-4418-BC9A-C223B92D5B8E</gtr:id><gtr:outcomeId>5461ee3602c5d4.82433162</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>150000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>MRC National Institute for Medical Research (NIMR)</gtr:department><gtr:description>MRC Centre Directors Capital Fund</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>6176C75E-97CA-456F-AC5E-7966342DB43D</gtr:id><gtr:outcomeId>HwAEjfDcA7t</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2013-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>6000000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Strategic Award</gtr:description><gtr:end>2015-11-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>6C88C05D-30D2-4507-BA35-A3EF5FB12181</gtr:id><gtr:outcomeId>n4mBgs5mk3H0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2994801</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>BMGF Global Health Award</gtr:description><gtr:end>2014-07-02</gtr:end><gtr:fundingOrg>Bill and Melinda Gates Foundation</gtr:fundingOrg><gtr:fundingRef>OPP1040463</gtr:fundingRef><gtr:id>23520535-16EA-4E90-B6FC-FF2B67EF393D</gtr:id><gtr:outcomeId>FU5x2r1wi5R</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1750000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Worldwide Antimalarial Resistance Network</gtr:description><gtr:fundingOrg>Bill and Melinda Gates Foundation</gtr:fundingOrg><gtr:id>0CE46D3C-BF51-40AE-9540-2DC0ABA7195F</gtr:id><gtr:outcomeId>p9MWLEYTGQM0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>105000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Centenary Award</gtr:description><gtr:end>2013-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>G0600718/1</gtr:fundingRef><gtr:id>32C5EADC-BF74-49A5-9B37-04BBABB0FCFA</gtr:id><gtr:outcomeId>MvTUggTVeFJ</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>4800000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>Global Health Program</gtr:description><gtr:end>2017-10-02</gtr:end><gtr:fundingOrg>Bill and Melinda Gates Foundation</gtr:fundingOrg><gtr:fundingRef>OPP1118166</gtr:fundingRef><gtr:id>45B34FAE-B9A9-4E98-BBF7-E46EE974502E</gtr:id><gtr:outcomeId>5461ecd039c152.27409430</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Panoptes is an open source software framework for collaborative visual exploration of large scale genome variation data and associated metadata in a web browser. It can be used to browse large, hybrid data sets in a coherent and user friendly way, and offers interactive visual analytics tools to assist the exploration.</gtr:description><gtr:id>E8ED5934-9887-44C5-9770-F00F30884632</gtr:id><gtr:impact>Example deployment: http://www.malariagen.net/apps/pf3k</gtr:impact><gtr:outcomeId>546206c978b205.69703079</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Panoptes</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type><gtr:url>https://github.com/cggh/panoptes</gtr:url><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We have developed and implemented mass-spec based methods for cost-effective SNP genotyping of 10,000's of samples from poor-quality samples from multicentre studies in Africa.</gtr:description><gtr:id>54D2A2C2-69F3-49A5-809E-EDAF5A57EF2C</gtr:id><gtr:impact>It has allowed us to provide genetic data on &amp;gt;100,000 samples for partners in &amp;gt;20 countries</gtr:impact><gtr:outcomeId>DE8C365E87F</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>High throughput genotyping methods</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2007</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>This is a specialist e-learning course for committees reviewing research at the FERCAP Conference in November 2012. The course focuses on ethical issues in genomic research.</gtr:description><gtr:id>3F2CD88E-7624-4B51-A93E-B9FDEF7D23E2</gtr:id><gtr:impact>This course is openly available through the Global Health Trails website (http://globalhealthtrials.tghn.org/) and forms part of a suite of e-learning courses of relevance to global health.</gtr:impact><gtr:outcomeId>CLtTw2fa3Eh</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>E learning - Ethics Committees Reviewing Genomic Research</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type><gtr:url>http://globalhealthtrials.tghn.org/</gtr:url><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>MapSeq is a web-based application designed to link deep genome sequencing to epidemiology, allowing exploration of genetic variation data in the context of geographical distributions and other phenotypic associations. MapSeq stores and manages genomic data from large numbers of samples, and presents this data in forms that make it easier to discern patterns and explore hypotheses.</gtr:description><gtr:id>6D65AF40-9C62-4A24-BCF2-48137C561CD5</gtr:id><gtr:impact>See www.mapseq.net/pf Featured in WIRED, Scientific American.</gtr:impact><gtr:outcomeId>1BD055CA772</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>MapSeq</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type><gtr:url>http://www.mapseq.net/pf</gtr:url><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>008E1A6B-FB22-409B-B1FB-573F2BB44B72</gtr:id><gtr:title>Host candidate gene polymorphisms and clearance of drug-resistant Plasmodium falciparum parasites.</gtr:title><gtr:parentPublicationTitle>Malaria journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f31e9b5c9ba942f7103fc3038abbcc67"><gtr:id>f31e9b5c9ba942f7103fc3038abbcc67</gtr:id><gtr:otherNames>Diakite M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1475-2875</gtr:issn><gtr:outcomeId>i7HwCH4W6Az</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C974E8B3-06C7-4C17-BD59-6E881D3ED617</gtr:id><gtr:title>Admixture into and within sub-Saharan Africa.</gtr:title><gtr:parentPublicationTitle>eLife</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b34c7cf30b8e4ba7fe0d6b01a8e02bf3"><gtr:id>b34c7cf30b8e4ba7fe0d6b01a8e02bf3</gtr:id><gtr:otherNames>Busby GB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2050-084X</gtr:issn><gtr:outcomeId>585d409b2bd5f0.47971163</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>24179E50-BCAB-4BA5-8719-5BC30B36FA78</gtr:id><gtr:title>Reappraisal of known malaria resistance loci in a large multicenter study.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/feeb66dfd531cddbcbb3d20136782331"><gtr:id>feeb66dfd531cddbcbb3d20136782331</gtr:id><gtr:otherNames>Malaria Genomic Epidemiology Network</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>56cafcacf360f5.49177305</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>15D783AA-BAC8-41DD-A934-65AA25EF56F4</gtr:id><gtr:title>Characterisation of the opposing effects of G6PD deficiency on cerebral malaria and severe malarial anaemia.</gtr:title><gtr:parentPublicationTitle>eLife</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/594bd789adb90dc75633762079f81315"><gtr:id>594bd789adb90dc75633762079f81315</gtr:id><gtr:otherNames>Clarke GM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2050-084X</gtr:issn><gtr:outcomeId>58b427378b6873.40091008</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4CA4D16B-0124-41DF-9606-6FEF5E9E5C68</gtr:id><gtr:title>Early pandemic influenza (2009 H1N1) in Ho Chi Minh City, Vietnam: a clinical virological and epidemiological analysis.</gtr:title><gtr:parentPublicationTitle>PLoS medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/437e506b883ddf573d6a763e877b0655"><gtr:id>437e506b883ddf573d6a763e877b0655</gtr:id><gtr:otherNames>Hien TT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1549-1277</gtr:issn><gtr:outcomeId>pm_12926_26_20502525</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AD161325-6D81-4A5B-BA9F-774CD8310021</gtr:id><gtr:title>Clinical features of severe malaria associated with death: a 13-year observational study in the Gambia.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5f21f1d98cd7f57fabc7b6af7b890e47"><gtr:id>5f21f1d98cd7f57fabc7b6af7b890e47</gtr:id><gtr:otherNames>Jallow M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_12926_26_23029157</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2D0B78E6-E07F-4A87-BEED-97B6EFA7661C</gtr:id><gtr:title>Independent emergence of artemisinin resistance mutations among Plasmodium falciparum in Southeast Asia.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/00e061d4d39077335c0e9cc17095af42"><gtr:id>00e061d4d39077335c0e9cc17095af42</gtr:id><gtr:otherNames>Takala-Harrison S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn><gtr:outcomeId>5461f534eb5548.03075554</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B12F561B-F10E-4808-881F-87A0C2BE1026</gtr:id><gtr:title>Genetic association study for RSV bronchiolitis in infancy at the 5q31 cytokine cluster.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4870a16829bec7267c64dd9870fb6734"><gtr:id>4870a16829bec7267c64dd9870fb6734</gtr:id><gtr:otherNames>Forton JT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn><gtr:outcomeId>86E32A145A9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C97F2915-1A4E-4E59-8A33-8502FE0543DC</gtr:id><gtr:title>Genetic determinants of anti-malarial acquired immunity in a large multi-centre study.</gtr:title><gtr:parentPublicationTitle>Malaria journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a2461536d0f6cacdea95fe5e5d6bdfb2"><gtr:id>a2461536d0f6cacdea95fe5e5d6bdfb2</gtr:id><gtr:otherNames>Shelton JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1475-2875</gtr:issn><gtr:outcomeId>5675ead7bd563</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>885ECE5C-35C5-4986-91D8-52DBD9F2C359</gtr:id><gtr:title>Conjunctival fibrosis and the innate barriers to Chlamydia trachomatis intracellular infection: a genome wide association study.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/32b758852c71a2a364d543a80f877171"><gtr:id>32b758852c71a2a364d543a80f877171</gtr:id><gtr:otherNames>Roberts Ch</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>585d5530d4a1e6.25390413</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2867E531-CBC6-4598-B747-5B3B2AEE5B12</gtr:id><gtr:title>Characterization of within-host Plasmodium falciparum diversity using next-generation sequence data.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c1637c64bfb7cbdd99a0444713efdb96"><gtr:id>c1637c64bfb7cbdd99a0444713efdb96</gtr:id><gtr:otherNames>Auburn S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_12926_26_22393456</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E026EFE1-27EA-41B2-ADB7-00FBF71738DC</gtr:id><gtr:title>Recent avian influenza virus A/H5N1 evolution in vaccinated and unvaccinated poultry from farms in Southern Vietnam, January-March 2010.</gtr:title><gtr:parentPublicationTitle>Transboundary and emerging diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5eb318d0e8ec82a27dd6f48cdac137b8"><gtr:id>5eb318d0e8ec82a27dd6f48cdac137b8</gtr:id><gtr:otherNames>Long NT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1865-1674</gtr:issn><gtr:outcomeId>pm_12926_26_21586098</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C77FA623-7814-462F-A366-7370D60EF6AF</gtr:id><gtr:title>Imputation-based meta-analysis of severe malaria in three African populations.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/184a9cdbbe27e8d87b2ff264d07e7075"><gtr:id>184a9cdbbe27e8d87b2ff264d07e7075</gtr:id><gtr:otherNames>Band G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>doi_12926_en_1003509</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>93C5F4FA-D24C-41EF-9031-5B1DBCD400A5</gtr:id><gtr:title>Monitoring parasite diversity for malaria elimination in sub-Saharan Africa.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2fa50662721e3299542a7d46e01dc2df"><gtr:id>2fa50662721e3299542a7d46e01dc2df</gtr:id><gtr:otherNames>Ghansah A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>5461f3ab6a1857.59476766</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1C5D72E6-AB0A-4B5C-9631-E30CCFECC6A8</gtr:id><gtr:title>Whole genome sequencing of Plasmodium falciparum from dried blood spots using selective whole genome amplification.</gtr:title><gtr:parentPublicationTitle>Malaria journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ee43912ff375f45704704105ce9b8cf3"><gtr:id>ee43912ff375f45704704105ce9b8cf3</gtr:id><gtr:otherNames>Oyola SO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1475-2875</gtr:issn><gtr:outcomeId>58b42902aec184.30678039</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D27EFBFF-6886-42FB-9043-06784EDD8074</gtr:id><gtr:title>Heterogeneous alleles comprising G6PD deficiency trait in West Africa exert contrasting effects on two major clinical presentations of severe malaria.</gtr:title><gtr:parentPublicationTitle>Malaria journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/61eefddb3ed1c984665dfb409a32b98e"><gtr:id>61eefddb3ed1c984665dfb409a32b98e</gtr:id><gtr:otherNames>Shah SS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1475-2875</gtr:issn><gtr:outcomeId>56cafad3a145c3.35695661</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2C90B623-63CB-455E-85D0-4F6B59539B5C</gtr:id><gtr:title>A novel cytofluorometric assay for the detection and quantification of glucose-6-phosphate dehydrogenase deficiency.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/61eefddb3ed1c984665dfb409a32b98e"><gtr:id>61eefddb3ed1c984665dfb409a32b98e</gtr:id><gtr:otherNames>Shah SS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>pm_12926_26_22393475</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FA95390C-3308-482F-885E-315A489197EB</gtr:id><gtr:title>Drug-resistant genotypes and multi-clonality in Plasmodium falciparum analysed by direct genome sequencing from peripheral blood of malaria patients.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c2b0028a2fcf920d73773ca3a4b04a49"><gtr:id>c2b0028a2fcf920d73773ca3a4b04a49</gtr:id><gtr:otherNames>Robinson T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>rKFVwQfwx6G</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>85C88786-AF56-4EDB-8E25-0F12E6A3210E</gtr:id><gtr:title>Analysis of anti-malarial resistance markers in pfmdr1 and pfcrt across Southeast Asia in the Tracking Resistance to Artemisinin Collaboration.</gtr:title><gtr:parentPublicationTitle>Malaria journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a323455a3b4123ae42c8a262ed64cfa2"><gtr:id>a323455a3b4123ae42c8a262ed64cfa2</gtr:id><gtr:otherNames>Srimuang K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1475-2875</gtr:issn><gtr:outcomeId>585d3cb84f05e3.42743470</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4D2DF6AB-B2BD-4B72-BB4D-04C5C3473C5C</gtr:id><gtr:title>Environmental Correlation Analysis for Genes Associated with Protection against Malaria.</gtr:title><gtr:parentPublicationTitle>Molecular biology and evolution</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/55da749f70a7badca8bd5df66c4ca44a"><gtr:id>55da749f70a7badca8bd5df66c4ca44a</gtr:id><gtr:otherNames>Mackinnon MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0737-4038</gtr:issn><gtr:outcomeId>585d660d65fe63.75982333</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B10DC9EA-D099-43CD-92BC-75CB0803AFC5</gtr:id><gtr:title>Genome-wide comparisons of variation in linkage disequilibrium.</gtr:title><gtr:parentPublicationTitle>Genome research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/81562ece86659bc9440adfcdc6069366"><gtr:id>81562ece86659bc9440adfcdc6069366</gtr:id><gtr:otherNames>Teo YY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1088-9051</gtr:issn><gtr:outcomeId>7FBC9009C4E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>222B3287-165C-42AE-AFD1-4B7C2EE50B29</gtr:id><gtr:title>Genetic loci associated with delayed clearance of Plasmodium falciparum following artemisinin treatment in Southeast Asia.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/00e061d4d39077335c0e9cc17095af42"><gtr:id>00e061d4d39077335c0e9cc17095af42</gtr:id><gtr:otherNames>Takala-Harrison S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>doi_12926_1211205110</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1F641133-12A5-4880-9323-C3EAD654AACB</gtr:id><gtr:title>Methodological challenges of genome-wide association analysis in Africa.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/81562ece86659bc9440adfcdc6069366"><gtr:id>81562ece86659bc9440adfcdc6069366</gtr:id><gtr:otherNames>Teo YY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1471-0056</gtr:issn><gtr:outcomeId>tqjYGJYDFkt</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3C4D9CFF-8858-4214-8595-3FDCF3C2D3AD</gtr:id><gtr:title>African glucose-6-phosphate dehydrogenase alleles associated with protection from severe malaria in heterozygous females in Tanzania.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/04b51454b7779504ab271ad8bae5b911"><gtr:id>04b51454b7779504ab271ad8bae5b911</gtr:id><gtr:otherNames>Manjurano A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>doi_55f984984048f054</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>26F72344-B49B-4132-826A-D9ADB9EBB57A</gtr:id><gtr:title>Massive introgression drives species radiation at the range limit of Anopheles gambiae.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/27abdf7ea5f8f5b01404bacc77ea7027"><gtr:id>27abdf7ea5f8f5b01404bacc77ea7027</gtr:id><gtr:otherNames>Vicente JL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>5aa6a079cb8a62.56567043</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D53044B6-A66C-468F-9D76-C43104BFC12D</gtr:id><gtr:title>Guidelines for identifying homologous recombination events in influenza A virus.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/03767063eb87b3b39cbb26d42fe9e5eb"><gtr:id>03767063eb87b3b39cbb26d42fe9e5eb</gtr:id><gtr:otherNames>Boni MF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_12926_26_20454662</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E7A2086C-25FD-4316-B230-A4C48B37F283</gtr:id><gtr:title>Artemisinin-resistant Plasmodium falciparum clinical isolates can infect diverse mosquito vectors of Southeast Asia and Africa.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/752ff954b5b42cab6d1ea64c6d2d990a"><gtr:id>752ff954b5b42cab6d1ea64c6d2d990a</gtr:id><gtr:otherNames>St Laurent B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>585d5693cc57f1.16291619</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1CD81E1C-5CB8-4431-8EDD-805C0C050B8E</gtr:id><gtr:title>Optimized whole-genome amplification strategy for extremely AT-biased template.</gtr:title><gtr:parentPublicationTitle>DNA research : an international journal for rapid publication of reports on genes and genomes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ee43912ff375f45704704105ce9b8cf3"><gtr:id>ee43912ff375f45704704105ce9b8cf3</gtr:id><gtr:otherNames>Oyola SO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1340-2838</gtr:issn><gtr:outcomeId>5461f3ab40f1a7.58174968</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E9CB7B8A-C04B-4F96-BB3F-393CE90499A3</gtr:id><gtr:title>A novel locus of resistance to severe malaria in a region of ancient balancing selection.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/feeb66dfd531cddbcbb3d20136782331"><gtr:id>feeb66dfd531cddbcbb3d20136782331</gtr:id><gtr:otherNames>Malaria Genomic Epidemiology Network</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>5675ec0cef782</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5F9F3997-E6AD-473C-B915-27FB942D2B8B</gtr:id><gtr:title>Inferring Strain Mixture within Clinical Plasmodium falciparum Isolates from Genomic Sequence Data.</gtr:title><gtr:parentPublicationTitle>PLoS computational biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bf51097c9577e63f13fcf03fc795365f"><gtr:id>bf51097c9577e63f13fcf03fc795365f</gtr:id><gtr:otherNames>O'Brien JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1553-734X</gtr:issn><gtr:outcomeId>585d3ddbdffd51.59830800</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0BFD593C-FF0D-4D98-A886-2A86CF2BAE1C</gtr:id><gtr:title>Investigation of host candidate malaria-associated risk/protective SNPs in a Brazilian Amazonian population.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/31dbb8b6b041b8d304c2602dd04d0700"><gtr:id>31dbb8b6b041b8d304c2602dd04d0700</gtr:id><gtr:otherNames>da Silva Santos S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_12926_26_22615793</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9B23FB35-B7A6-4DB3-8070-DEF2CF7630A7</gtr:id><gtr:title>Genomic epidemiology of artemisinin resistant malaria.</gtr:title><gtr:parentPublicationTitle>eLife</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f8158a7b97f9cda79f60ba71ee6a6a75"><gtr:id>f8158a7b97f9cda79f60ba71ee6a6a75</gtr:id><gtr:otherNames>MalariaGEN Plasmodium falciparum Community Project</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2050-084X</gtr:issn><gtr:outcomeId>56dd64c0241be4.84787964</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2A8F3177-E481-4AF0-BF8F-4D496A2E85A6</gtr:id><gtr:title>Polymorphisms in chloroquine resistance-associated genes in Plasmodium vivax in Ethiopia.</gtr:title><gtr:parentPublicationTitle>Malaria journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7394ec46e50707e489affb03fad4b738"><gtr:id>7394ec46e50707e489affb03fad4b738</gtr:id><gtr:otherNames>Golassa L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1475-2875</gtr:issn><gtr:outcomeId>doi_55f9849840357832</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>77A0FB57-CD63-42C6-B6F0-A030E0A3A67A</gtr:id><gtr:title>Changes in malaria parasite drug resistance in an endemic population over a 25-year period with resulting genomic evidence of selection.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8d17217a91ffab5a3cc6df8fd797dcf4"><gtr:id>8d17217a91ffab5a3cc6df8fd797dcf4</gtr:id><gtr:otherNames>Nwakanma DC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn><gtr:outcomeId>pm_540e14ce14c0c3af3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>205C1CF5-9D02-4FB2-AB73-E8938C9AED4C</gtr:id><gtr:title>SnoopCGH: software for visualizing comparative genomic hybridization data.</gtr:title><gtr:parentPublicationTitle>Bioinformatics (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/502846ac2fe421dee3260e1de6522ca2"><gtr:id>502846ac2fe421dee3260e1de6522ca2</gtr:id><gtr:otherNames>Almagro-Garcia J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1367-4803</gtr:issn><gtr:outcomeId>50755B41514</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7A95CD31-212C-49E1-B48A-8E60C79475C8</gtr:id><gtr:title>Dengue dynamics in Binh Thuan province, southern Vietnam: periodicity, synchronicity and climate variability.</gtr:title><gtr:parentPublicationTitle>PLoS neglected tropical diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1617ca22a4db8e6b0dc8dff0aa774fcb"><gtr:id>1617ca22a4db8e6b0dc8dff0aa774fcb</gtr:id><gtr:otherNames>Thai KT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1935-2727</gtr:issn><gtr:outcomeId>pm_12926_26_20644621</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>657C8F10-638C-4137-9AEB-9FD949F212C1</gtr:id><gtr:title>Optimizing Illumina next-generation sequencing library preparation for extremely AT-biased genomes.</gtr:title><gtr:parentPublicationTitle>BMC genomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ee43912ff375f45704704105ce9b8cf3"><gtr:id>ee43912ff375f45704704105ce9b8cf3</gtr:id><gtr:otherNames>Oyola SO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1471-2164</gtr:issn><gtr:outcomeId>pm_12926_26_22214261</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>059A7495-B662-4D51-BEAB-CCC3592FA1C1</gtr:id><gtr:title>A transcriptional switch underlies commitment to sexual development in malaria parasites.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c45025d5c4b3838d59823874e1446062"><gtr:id>c45025d5c4b3838d59823874e1446062</gtr:id><gtr:otherNames>Kafsack BF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>pm_540e149e149328f02</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6BA1C9CB-3510-4069-8FE9-D6B32837E794</gtr:id><gtr:title>Tumor necrosis factor and lymphotoxin-alpha polymorphisms and severe malaria in African populations.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7b6cf9a3f2fbd3d841d9132978ec3e1c"><gtr:id>7b6cf9a3f2fbd3d841d9132978ec3e1c</gtr:id><gtr:otherNames>Clark TG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn><gtr:outcomeId>hEeGJPjLgvQ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1631E4E4-5948-469B-A8E1-DEDC0CE05859</gtr:id><gtr:title>Investigating the potential for ethnic group harm in collaborative genomics research in Africa: is ethnic stigmatisation likely?</gtr:title><gtr:parentPublicationTitle>Social science &amp; medicine (1982)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cf975219a341ef6a0ad35edc39efed7d"><gtr:id>cf975219a341ef6a0ad35edc39efed7d</gtr:id><gtr:otherNames>de Vries J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0277-9536</gtr:issn><gtr:outcomeId>doi_55f983983d0bc280</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>295A0BD0-1038-43BA-9C9F-E02C160F0F9D</gtr:id><gtr:title>Knowing who to trust: exploring the role of 'ethical metadata' in mediating risk of harm in collaborative genomics research in Africa.</gtr:title><gtr:parentPublicationTitle>BMC medical ethics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cf975219a341ef6a0ad35edc39efed7d"><gtr:id>cf975219a341ef6a0ad35edc39efed7d</gtr:id><gtr:otherNames>de Vries J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1472-6939</gtr:issn><gtr:outcomeId>5461f5351d9543.96974048</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E8B83BF1-D2F4-4B02-8D38-226F4BCF68DB</gtr:id><gtr:title>Glucose-6-phosphate dehydrogenase deficiency among malaria suspects attending Gambella hospital, southwest Ethiopia.</gtr:title><gtr:parentPublicationTitle>Malaria journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/52332cf6411945c3f06e7e6589c0e8a6"><gtr:id>52332cf6411945c3f06e7e6589c0e8a6</gtr:id><gtr:otherNames>Tsegaye A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1475-2875</gtr:issn><gtr:outcomeId>5675dce679197</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ABE2FD88-B064-4A83-9F96-0882880D7ED8</gtr:id><gtr:title>Genetic diversity of the African malaria vector Anopheles gambiae.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/27270c0e4754e0bdf2e6597a3aa5de20"><gtr:id>27270c0e4754e0bdf2e6597a3aa5de20</gtr:id><gtr:otherNames>Anopheles gambiae 1000 Genomes Consortium</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>5aaa6d74d74583.37526745</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6A7875BF-8942-4778-8EF2-C8341443F3B1</gtr:id><gtr:title>Allelic heterogeneity of G6PD deficiency in West Africa and severe malaria susceptibility.</gtr:title><gtr:parentPublicationTitle>European journal of human genetics : EJHG</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7b6cf9a3f2fbd3d841d9132978ec3e1c"><gtr:id>7b6cf9a3f2fbd3d841d9132978ec3e1c</gtr:id><gtr:otherNames>Clark TG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1018-4813</gtr:issn><gtr:outcomeId>ahmWDC6YnmS</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E6407520-F4AD-4A1E-9523-3AE3724E5A52</gtr:id><gtr:title>Glucose-6-phosphate dehydrogenase deficiency and the risk of malaria and other diseases in children in Kenya: a case-control and a cohort study.</gtr:title><gtr:parentPublicationTitle>The Lancet. Haematology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5dd76418b4f58b8a1bbff706c80028f6"><gtr:id>5dd76418b4f58b8a1bbff706c80028f6</gtr:id><gtr:otherNames>Uyoga S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2352-3026</gtr:issn><gtr:outcomeId>5675fb9f8ba34</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>312E5809-2E39-4765-918B-DC8319389262</gtr:id><gtr:title>Optimum population-level use of artemisinin combination therapies: a modelling study.</gtr:title><gtr:parentPublicationTitle>The Lancet. Global health</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/99e76baa241a1617b0715a47b47521b1"><gtr:id>99e76baa241a1617b0715a47b47521b1</gtr:id><gtr:otherNames>Nguyen TD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2214-109X</gtr:issn><gtr:outcomeId>585d5618051032.28981279</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1DF9AB3C-9D8B-476C-BA7E-99D94CE7F526</gtr:id><gtr:title>Candidate human genetic polymorphisms and severe malaria in a Tanzanian population.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/04b51454b7779504ab271ad8bae5b911"><gtr:id>04b51454b7779504ab271ad8bae5b911</gtr:id><gtr:otherNames>Manjurano A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_12926_26_23144702</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>93FD19B3-B7B8-4C77-A5A7-1A962506A9AF</gtr:id><gtr:title>Genomic Analysis Reveals a Common Breakpoint in Amplifications of the Plasmodium vivax Multidrug Resistance 1 Locus in Thailand.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c1637c64bfb7cbdd99a0444713efdb96"><gtr:id>c1637c64bfb7cbdd99a0444713efdb96</gtr:id><gtr:otherNames>Auburn S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn><gtr:outcomeId>58b429be88a284.28995305</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CEF053D4-5D8A-4ECD-ACB8-29C35699A1AD</gtr:id><gtr:title>Ethical issues in human genomics research in developing countries.</gtr:title><gtr:parentPublicationTitle>BMC medical ethics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cf975219a341ef6a0ad35edc39efed7d"><gtr:id>cf975219a341ef6a0ad35edc39efed7d</gtr:id><gtr:otherNames>de Vries J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1472-6939</gtr:issn><gtr:outcomeId>pm_12926_26_21418562</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E959CFEC-8EED-4605-9552-5361943E2769</gtr:id><gtr:title>Generation of antigenic diversity in Plasmodium falciparum by structured rearrangement of Var genes during mitosis.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/701c8c6475b5e94744c0ce4d1d2f8419"><gtr:id>701c8c6475b5e94744c0ce4d1d2f8419</gtr:id><gtr:otherNames>Claessens A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>doi_55f984984040090a</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EE116091-36F6-47D1-95DD-4A501FAFE1B6</gtr:id><gtr:title>Variation in human genes encoding adhesion and proinflammatory molecules are associated with severe malaria in the Vietnamese.</gtr:title><gtr:parentPublicationTitle>Genes and immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3a4771316c7e1dbe5372ebf904680c01"><gtr:id>3a4771316c7e1dbe5372ebf904680c01</gtr:id><gtr:otherNames>Dunstan SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1466-4879</gtr:issn><gtr:outcomeId>pm_12926_26_22673309</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2B4F5A17-E1BE-424C-92D9-8D82EB94D6C2</gtr:id><gtr:title>Assessing genuine parents-offspring trios for genetic association studies.</gtr:title><gtr:parentPublicationTitle>Human heredity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/81562ece86659bc9440adfcdc6069366"><gtr:id>81562ece86659bc9440adfcdc6069366</gtr:id><gtr:otherNames>Teo YY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0001-5652</gtr:issn><gtr:outcomeId>LMc5RUWhxPf</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>65C45426-A628-4D54-9AA7-2D8613F9FC01</gtr:id><gtr:title>A genome wide association study of Plasmodium falciparum susceptibility to 22 antimalarial drugs in Kenya.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/50bd36c841b67fa5fd235c13e265c140"><gtr:id>50bd36c841b67fa5fd235c13e265c140</gtr:id><gtr:otherNames>Wendler JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_540e14ce14c46bd9b</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CAFB4FF8-C476-4813-B860-E7823979624E</gtr:id><gtr:title>SNP-o-matic.</gtr:title><gtr:parentPublicationTitle>Bioinformatics (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8ebdff396c6bddcd88c000533e7b6309"><gtr:id>8ebdff396c6bddcd88c000533e7b6309</gtr:id><gtr:otherNames>Manske HM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1367-4803</gtr:issn><gtr:outcomeId>467C8452CB6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F302C806-EC47-4B5A-B78C-700F24960138</gtr:id><gtr:title>A changing picture of shigellosis in southern Vietnam: shifting species dominance, antimicrobial susceptibility and clinical presentation.</gtr:title><gtr:parentPublicationTitle>BMC infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c7f5ac44a9d0dd31c3eb77820218c00a"><gtr:id>c7f5ac44a9d0dd31c3eb77820218c00a</gtr:id><gtr:otherNames>Vinh H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1471-2334</gtr:issn><gtr:outcomeId>pm_12926_26_20003464</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>67279F7B-6115-426B-A3A2-0C8F849B1A0F</gtr:id><gtr:title>Multiple populations of artemisinin-resistant Plasmodium falciparum in Cambodia.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/75c4cab9c5760d4acbdaeb780d2b0b6b"><gtr:id>75c4cab9c5760d4acbdaeb780d2b0b6b</gtr:id><gtr:otherNames>Miotto O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>doi_12926_38_ng_2624</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5101F62A-E2B6-4208-8AE5-F1E712B27121</gtr:id><gtr:title>Extreme mutation bias and high AT content in Plasmodium falciparum.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/12dd20fdd2e413ecf5539a752e3e37c3"><gtr:id>12dd20fdd2e413ecf5539a752e3e37c3</gtr:id><gtr:otherNames>Hamilton WL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>5a360ab8f18e74.99909309</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>89832619-821C-4DFB-961A-D060BEC032B1</gtr:id><gtr:title>Novel Insights Into the Protective Role of Hemoglobin S and C Against Plasmodium falciparum Parasitemia.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/352f94038690397c8c6983b598a6fb3f"><gtr:id>352f94038690397c8c6983b598a6fb3f</gtr:id><gtr:otherNames>Mangano VD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn><gtr:outcomeId>5675e01a4edeb</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5ED98EBF-70B1-404A-8D3E-796C7709C9CD</gtr:id><gtr:title>Candidate polymorphisms and severe malaria in a Malian population.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/31822c14c5a3a09e9f8f63c9abe7e7d8"><gtr:id>31822c14c5a3a09e9f8f63c9abe7e7d8</gtr:id><gtr:otherNames>Toure O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_12926_26_22957039</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D51CDC0E-FA20-49E7-9351-AD7BACCED776</gtr:id><gtr:title>Origins of the current outbreak of multidrug-resistant malaria in southeast Asia: a retrospective genetic study.</gtr:title><gtr:parentPublicationTitle>The Lancet. Infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d2e9ae7a6d640e097797c327e77f8127"><gtr:id>d2e9ae7a6d640e097797c327e77f8127</gtr:id><gtr:otherNames>Amato R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1473-3099</gtr:issn><gtr:outcomeId>5aa6a0797a25b2.54985720</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>665C1708-19FB-46CE-A1FE-3B5EE306E783</gtr:id><gtr:title>Seeking consent to genetic and genomic research in a rural Ghanaian setting: a qualitative study of the MalariaGEN experience.</gtr:title><gtr:parentPublicationTitle>BMC medical ethics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/412e191c43628711348d2c59ce161cfc"><gtr:id>412e191c43628711348d2c59ce161cfc</gtr:id><gtr:otherNames>Tindana P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1472-6939</gtr:issn><gtr:outcomeId>pm_12926_26_22747883</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3EEFC011-E6D5-430E-A8D4-C067AC7C93F0</gtr:id><gtr:title>Genetic architecture of artemisinin-resistant Plasmodium falciparum.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/75c4cab9c5760d4acbdaeb780d2b0b6b"><gtr:id>75c4cab9c5760d4acbdaeb780d2b0b6b</gtr:id><gtr:otherNames>Miotto O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>doi_55faa1aa1b98a788</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5689619A-F0C4-41E1-B45C-94D7626A48A3</gtr:id><gtr:title>The African Genome Variation Project shapes medical genetics in Africa.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/028c877b2dbe31d6e55c00dfe30822ee"><gtr:id>028c877b2dbe31d6e55c00dfe30822ee</gtr:id><gtr:otherNames>Gurdasani D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>doi_55faa1aa1b8d53ac</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2EE54E0A-DD6F-4AEB-A906-7DDC4990E0B0</gtr:id><gtr:title>A genetic association study in the Gambia using tagging polymorphisms in the major histocompatibility complex class III region implicates a HLA-B associated transcript 2 polymorphism in severe malaria susceptibility.</gtr:title><gtr:parentPublicationTitle>Human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f31e9b5c9ba942f7103fc3038abbcc67"><gtr:id>f31e9b5c9ba942f7103fc3038abbcc67</gtr:id><gtr:otherNames>Diakite M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0340-6717</gtr:issn><gtr:outcomeId>B00832B1A5B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8A4E2892-9755-410E-A492-962994B72BB3</gtr:id><gtr:title>K13-propeller polymorphisms in Plasmodium falciparum parasites from sub-Saharan Africa.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3e516e23cb40d58db86a1a4d61d1edd3"><gtr:id>3e516e23cb40d58db86a1a4d61d1edd3</gtr:id><gtr:otherNames>Kamau E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn><gtr:outcomeId>5675dc8d559b1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FAF82485-2DD3-4E24-B2D1-A4F214DAD608</gtr:id><gtr:title>Malaria genomics: tracking a diverse and evolving parasite population.</gtr:title><gtr:parentPublicationTitle>International health</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bc5b558b36b950b68141abd8e16ce0b3"><gtr:id>bc5b558b36b950b68141abd8e16ce0b3</gtr:id><gtr:otherNames>Kwiatkowski D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1876-3405</gtr:issn><gtr:outcomeId>doi_55f984984018be47</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>047B160B-1224-482F-AE32-3C739778C5B7</gtr:id><gtr:title>LookSeq: a browser-based viewer for deep sequencing data.</gtr:title><gtr:parentPublicationTitle>Genome research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8ebdff396c6bddcd88c000533e7b6309"><gtr:id>8ebdff396c6bddcd88c000533e7b6309</gtr:id><gtr:otherNames>Manske HM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1088-9051</gtr:issn><gtr:outcomeId>91F9784CEED</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>567FE56E-8B70-4E9A-BC8D-5C8A41A2B87E</gtr:id><gtr:title>G6PD gene variants and its association with malaria in a Sri Lankan population.</gtr:title><gtr:parentPublicationTitle>Malaria journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/59c8927f7fa3f82838cb87de38be2f70"><gtr:id>59c8927f7fa3f82838cb87de38be2f70</gtr:id><gtr:otherNames>Dewasurendra RL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1475-2875</gtr:issn><gtr:outcomeId>doi_55f98498402b8d68</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9FEAA9D6-E59B-4C58-B7F4-CFB8EDD9C164</gtr:id><gtr:title>Power consequences of linkage disequilibrium variation between populations.</gtr:title><gtr:parentPublicationTitle>Genetic epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/81562ece86659bc9440adfcdc6069366"><gtr:id>81562ece86659bc9440adfcdc6069366</gtr:id><gtr:otherNames>Teo YY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0741-0395</gtr:issn><gtr:outcomeId>hkyjWJBeGfG</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6889FB44-D925-45F3-961B-F7AD04835B47</gtr:id><gtr:title>High-level Plasmodium falciparum sulfadoxine-pyrimethamine resistance with the concomitant occurrence of septuple haplotype in Tanzania.</gtr:title><gtr:parentPublicationTitle>Malaria journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fc3964362d63df9b93ce6ec87b771021"><gtr:id>fc3964362d63df9b93ce6ec87b771021</gtr:id><gtr:otherNames>Baraka V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1475-2875</gtr:issn><gtr:outcomeId>585d55e10ae101.89956123</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A559063E-B5F4-4960-8744-BF41CAE3557B</gtr:id><gtr:title>A global network for investigating the genomic epidemiology of malaria.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/feeb66dfd531cddbcbb3d20136782331"><gtr:id>feeb66dfd531cddbcbb3d20136782331</gtr:id><gtr:otherNames>Malaria Genomic Epidemiology Network</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>AKCZov6bGKd</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3EB7BEA5-31F2-4D60-A30A-65A5EA0C42BF</gtr:id><gtr:title>Human candidate polymorphisms in sympatric ethnic groups differing in malaria susceptibility in Mali.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/311f5170e30802e247a129d0bc9c7053"><gtr:id>311f5170e30802e247a129d0bc9c7053</gtr:id><gtr:otherNames>Maiga B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>doi_55f9849840550bb9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A110CCCF-B5BF-4BF1-BE5F-A5995F83394D</gtr:id><gtr:title>Population genetic structure and adaptation of malaria parasites on the edge of endemic distribution.</gtr:title><gtr:parentPublicationTitle>Molecular ecology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/757dd93bb68c396232c8d9dba73a6e55"><gtr:id>757dd93bb68c396232c8d9dba73a6e55</gtr:id><gtr:otherNames>Duffy CW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0962-1083</gtr:issn><gtr:outcomeId>58b43002cb73f2.28883848</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>03A3E0FB-924E-4CE9-9A95-6D516FBD1906</gtr:id><gtr:title>A molecular marker of artemisinin-resistant Plasmodium falciparum malaria.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/86b6a369eb04aa8e6779f94d4e2b60af"><gtr:id>86b6a369eb04aa8e6779f94d4e2b60af</gtr:id><gtr:otherNames>Ariey F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>pm_540e14ce14c2653ae</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8E72E619-6538-4909-9566-EED8727333D9</gtr:id><gtr:title>Genetic polymorphisms associated with anti-malarial antibody levels in a low and unstable malaria transmission area in southern Sri Lanka.</gtr:title><gtr:parentPublicationTitle>Malaria journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/59c8927f7fa3f82838cb87de38be2f70"><gtr:id>59c8927f7fa3f82838cb87de38be2f70</gtr:id><gtr:otherNames>Dewasurendra RL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1475-2875</gtr:issn><gtr:outcomeId>pm_12926_26_22905743</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8AF9645F-55E2-4939-8374-291F45D8AEB9</gtr:id><gtr:title>Understandings of genomic research in developing countries: a qualitative study of the views of MalariaGEN participants in Mali.</gtr:title><gtr:parentPublicationTitle>BMC medical ethics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/950cd5ebbae4f1d85c027c7dd28b9bc4"><gtr:id>950cd5ebbae4f1d85c027c7dd28b9bc4</gtr:id><gtr:otherNames>Traore K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1472-6939</gtr:issn><gtr:outcomeId>5675e690b0f47</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0FB29A58-2E05-44C1-88EB-AFBF662E8F46</gtr:id><gtr:title>A Toll-like receptor-1 variant and its characteristic cellular phenotype is associated with severe malaria in Papua New Guinean children.</gtr:title><gtr:parentPublicationTitle>Genes and immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6921b5c79e1a40be623c2619cceb9a01"><gtr:id>6921b5c79e1a40be623c2619cceb9a01</gtr:id><gtr:otherNames>Manning L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1466-4879</gtr:issn><gtr:outcomeId>585d55024e95d5.24789071</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8BDFC768-F40E-4CF0-BC0E-B08E4FCDC6C8</gtr:id><gtr:title>Population genetic analysis of Plasmodium falciparum parasites using a customized Illumina GoldenGate genotyping assay.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/74857d2b9bd60c065bebd0bd630bb80d"><gtr:id>74857d2b9bd60c065bebd0bd630bb80d</gtr:id><gtr:otherNames>Campino S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>GBQ42ZszghK</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6314696E-D150-43B0-828D-58FC67BC4EF9</gtr:id><gtr:title>Ethical data release in genome-wide association studies in developing countries.</gtr:title><gtr:parentPublicationTitle>PLoS medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b6c6b0bd68dab83386da1c22aa5e1376"><gtr:id>b6c6b0bd68dab83386da1c22aa5e1376</gtr:id><gtr:otherNames>Parker M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1549-1277</gtr:issn><gtr:outcomeId>1D1D7914E06</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DAC86D4D-7481-4AC8-8096-F44AE6423543</gtr:id><gtr:title>Haplotype analyses of haemoglobin C and haemoglobin S and the dynamics of the evolutionary response to malaria in Kassena-Nankana District of Ghana.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2fa50662721e3299542a7d46e01dc2df"><gtr:id>2fa50662721e3299542a7d46e01dc2df</gtr:id><gtr:otherNames>Ghansah A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_12926_26_22506028</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>048B2D15-8BAD-4AD0-8FAF-51F853391B84</gtr:id><gtr:title>Genome-wide and fine-resolution association analysis of malaria in West Africa.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5f21f1d98cd7f57fabc7b6af7b890e47"><gtr:id>5f21f1d98cd7f57fabc7b6af7b890e47</gtr:id><gtr:otherNames>Jallow M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>nLPv8QNP8dM</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>927D3872-5246-4D7E-80CA-77F26C2907D0</gtr:id><gtr:title>The burden and characteristics of enteric fever at a healthcare facility in a densely populated area of Kathmandu.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7dc5204a6a5f780dfcd1867c7392b377"><gtr:id>7dc5204a6a5f780dfcd1867c7392b377</gtr:id><gtr:otherNames>Karkey A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_12926_26_21085575</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F27F8B1B-C6D9-4819-947B-B7869236886A</gtr:id><gtr:title>Using CF11 cellulose columns to inexpensively and effectively remove human DNA from Plasmodium falciparum-infected whole blood samples.</gtr:title><gtr:parentPublicationTitle>Malaria journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6bf081012201eb332d9ccccdc5b12d93"><gtr:id>6bf081012201eb332d9ccccdc5b12d93</gtr:id><gtr:otherNames>Venkatesan M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1475-2875</gtr:issn><gtr:outcomeId>pm_12926_26_22321373</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9CB8A5E7-7031-4B08-8CB9-7A5247191D8B</gtr:id><gtr:title>Identification of large variation in pfcrt, pfmdr-1 and pfubp-1 markers in Plasmodium falciparum isolates from Ethiopia and Tanzania.</gtr:title><gtr:parentPublicationTitle>Malaria journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7394ec46e50707e489affb03fad4b738"><gtr:id>7394ec46e50707e489affb03fad4b738</gtr:id><gtr:otherNames>Golassa L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1475-2875</gtr:issn><gtr:outcomeId>5675e80e6d24c</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C46EBC2F-A0D1-45DF-9704-D99398BBE352</gtr:id><gtr:title>Discovery and validation of biomarkers to guide clinical management of pneumonia in African children.</gtr:title><gtr:parentPublicationTitle>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e94754791b4be0de589dc01808c98d92"><gtr:id>e94754791b4be0de589dc01808c98d92</gtr:id><gtr:otherNames>Huang H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1058-4838</gtr:issn><gtr:outcomeId>pm_540e14ce14c3b4f78</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>47FCBEB8-4366-4DA0-9AF4-E0CD61730B8B</gtr:id><gtr:title>A Bayesian approach using covariance of single nucleotide polymorphism data to detect differences in linkage disequilibrium patterns between groups of individuals.</gtr:title><gtr:parentPublicationTitle>Bioinformatics (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7b6cf9a3f2fbd3d841d9132978ec3e1c"><gtr:id>7b6cf9a3f2fbd3d841d9132978ec3e1c</gtr:id><gtr:otherNames>Clark TG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1367-4803</gtr:issn><gtr:outcomeId>j51acow9kTL</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C2845EB5-5914-4FD6-9B2D-81A99C533EE7</gtr:id><gtr:title>Population genomic scan for candidate signatures of balancing selection to guide antigen characterization in malaria parasites.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0dc2dcf13cb60a8294fc0d56e088301a"><gtr:id>0dc2dcf13cb60a8294fc0d56e088301a</gtr:id><gtr:otherNames>Amambua-Ngwa A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>pm_12926_26_23133397</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A1705373-5764-4307-87E1-19D15371173C</gtr:id><gtr:title>Genome-wide analysis of selection on the malaria parasite Plasmodium falciparum in West African populations of differing infection endemicity.</gtr:title><gtr:parentPublicationTitle>Molecular biology and evolution</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8e29b1d8caca77358dfa48527127661a"><gtr:id>8e29b1d8caca77358dfa48527127661a</gtr:id><gtr:otherNames>Mobegi VA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0737-4038</gtr:issn><gtr:outcomeId>pm_540e14ce14c313cba</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>32CB76C3-413D-4D9C-A7B2-6B8A54E6A072</gtr:id><gtr:title>Tumour necrosis factor alpha promoter polymorphism, TNF-238 is associated with severe clinical outcome of falciparum malaria in Ibadan southwest Nigeria.</gtr:title><gtr:parentPublicationTitle>Acta tropica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3305c38047b5da3de8c0928817cd5267"><gtr:id>3305c38047b5da3de8c0928817cd5267</gtr:id><gtr:otherNames>Olaniyan SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0001-706X</gtr:issn><gtr:outcomeId>585d6606d2ac20.73892885</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E7A6DEB5-1AEF-4D60-BD6B-ABCC301F2AC0</gtr:id><gtr:title>Comparison of genomic signatures of selection on Plasmodium falciparum between different regions of a country with high malaria endemicity.</gtr:title><gtr:parentPublicationTitle>BMC genomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/757dd93bb68c396232c8d9dba73a6e55"><gtr:id>757dd93bb68c396232c8d9dba73a6e55</gtr:id><gtr:otherNames>Duffy CW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1471-2164</gtr:issn><gtr:outcomeId>5675e86fbd6eb</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>89E7A9A9-050E-43BF-8344-6AB23A1D173A</gtr:id><gtr:title>Genetic markers associated with dihydroartemisinin-piperaquine failure in Plasmodium falciparum malaria in Cambodia: a genotype-phenotype association study.</gtr:title><gtr:parentPublicationTitle>The Lancet. Infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d2e9ae7a6d640e097797c327e77f8127"><gtr:id>d2e9ae7a6d640e097797c327e77f8127</gtr:id><gtr:otherNames>Amato R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1473-3099</gtr:issn><gtr:outcomeId>58c917880375e0.31801932</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4BC1FD96-FEC0-491B-966F-8BC9B7377D44</gtr:id><gtr:title>Plasmodium malariae and P. ovale genomes provide insights into malaria parasite evolution.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7243861325bf99a7870deae2354d4cfc"><gtr:id>7243861325bf99a7870deae2354d4cfc</gtr:id><gtr:otherNames>Rutledge GG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>5aa6a07a1d60f2.83931657</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CA9834E5-9D76-4D18-B520-B6C00AC4C4D1</gtr:id><gtr:title>Analysis of Plasmodium falciparum diversity in natural infections by deep sequencing.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/deb1e094abfd32f08fd158cb4fa985ef"><gtr:id>deb1e094abfd32f08fd158cb4fa985ef</gtr:id><gtr:otherNames>Manske M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>pm_12926_26_22722859</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1D704421-4377-4E0D-A29D-49DE9E938FAE</gtr:id><gtr:title>An effective method to purify Plasmodium falciparum DNA directly from clinical blood samples for whole genome high-throughput sequencing.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c1637c64bfb7cbdd99a0444713efdb96"><gtr:id>c1637c64bfb7cbdd99a0444713efdb96</gtr:id><gtr:otherNames>Auburn S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>L9o5EJGcfoc</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5663DFE6-4E2A-4C05-A23F-0460746A7653</gtr:id><gtr:title>Association of cytokine and Toll-like receptor gene polymorphisms with severe malaria in three regions of Cameroon.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c331ffefa59854e98bd12782e3f9eb9f"><gtr:id>c331ffefa59854e98bd12782e3f9eb9f</gtr:id><gtr:otherNames>Apinjoh TO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_540e149e1492760d4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3D7EE756-C7B5-4824-A48A-5D86D6C2E90A</gtr:id><gtr:title>Glucose-6-phosphate dehydrogenase polymorphisms and susceptibility to mild malaria in Dogon and Fulani, Mali.</gtr:title><gtr:parentPublicationTitle>Malaria journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/311f5170e30802e247a129d0bc9c7053"><gtr:id>311f5170e30802e247a129d0bc9c7053</gtr:id><gtr:otherNames>Maiga B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1475-2875</gtr:issn><gtr:outcomeId>doi_55f9849840223a6e</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F00F0CD6-48D9-4656-AA37-3CB2CE827FE7</gtr:id><gtr:title>Detecting and characterizing genomic signatures of positive selection in global populations.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/42f7c7c6107a6cd7198876022cb295cf"><gtr:id>42f7c7c6107a6cd7198876022cb295cf</gtr:id><gtr:otherNames>Liu X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>doi_12926_013_04_021</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2BF03D8E-17EF-4B64-AA36-4E95737F3C14</gtr:id><gtr:title>Resistance to malaria through structural variation of red blood cell invasion receptors.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/318e66d904f7b6b4fc3e6ced1f5ec8f9"><gtr:id>318e66d904f7b6b4fc3e6ced1f5ec8f9</gtr:id><gtr:otherNames>Leffler EM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>5a2fda5b5e6771.72794638</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>67F4B667-857A-4B2C-BCB0-2EC6AF3F61CA</gtr:id><gtr:title>Association of candidate gene polymorphisms and TGF-beta/IL-10 levels with malaria in three regions of Cameroon: a case-control study.</gtr:title><gtr:parentPublicationTitle>Malaria journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c331ffefa59854e98bd12782e3f9eb9f"><gtr:id>c331ffefa59854e98bd12782e3f9eb9f</gtr:id><gtr:otherNames>Apinjoh TO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1475-2875</gtr:issn><gtr:outcomeId>pm_540e14ce14c51f755</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9BEE3AEA-0FEC-4F2A-8570-20F9222F9546</gtr:id><gtr:title>Enhancing blockade of Plasmodium falciparum erythrocyte invasion: assessing combinations of antibodies against PfRH5 and other merozoite antigens.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/60f32e856c91f8719ed1862e0d189adf"><gtr:id>60f32e856c91f8719ed1862e0d189adf</gtr:id><gtr:otherNames>Williams AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>pm_12926_26_23144611</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>39A03328-CAC6-446D-990F-54AF4E1C2904</gtr:id><gtr:title>Genomic analysis of local variation and recent evolution in Plasmodium vivax.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/16324044f930d368fa3b14f26ed5cf15"><gtr:id>16324044f930d368fa3b14f26ed5cf15</gtr:id><gtr:otherNames>Pearson RD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>585d660a7dc7c4.61929509</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>492FE533-0BAF-4086-A690-F0520EA0AFC4</gtr:id><gtr:title>Modelling the progression of pandemic influenza A (H1N1) in Vietnam and the opportunities for reassortment with other influenza viruses.</gtr:title><gtr:parentPublicationTitle>BMC medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/03767063eb87b3b39cbb26d42fe9e5eb"><gtr:id>03767063eb87b3b39cbb26d42fe9e5eb</gtr:id><gtr:otherNames>Boni MF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1741-7015</gtr:issn><gtr:outcomeId>pm_12926_16_19728864</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0600718</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>12A0B409-0C29-4056-9092-2D86E44017F3</gtr:id><gtr:percentage>34</gtr:percentage><gtr:text>1.4  Methodologies and measurements</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>33</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>8F896112-5A04-4A11-A9F0-2B446D9AAC8A</gtr:id><gtr:percentage>33</gtr:percentage><gtr:text>5.1  Pharmaceuticals</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>